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Chapter 1 
Introduction 
1.1 Indications for liver transplantation 
Although a wide variety of techniques has been devised to treat patients 
With end-stage liver disease, none has proven to be very effective. 
Exchange transfusion, plasmapheresis, cross circulation, extra corporeal 
liver perfusion, hemodialysis. and hemoperfusion have been unable to 
improve patient survival significantly1 . In view of the many complex 
tasks of the liver, it seems less likely that an effective artificial 
hepatic support device will become available in the near future. Liver 
~ransplantation thus represents at the moment the only treatment which 
offers hope for survival in children and adults with end-stage liver 
disease. 
Since 1963, when the first transplantation of a human liver was attempted 
by Starzl. over 1000 liver transplantations have been performed world 
wide2 . Until 1980 the one year survival rate was 30% with a five year 
survival rate of 20%. Improvement in surgical technique and changes in 
immunosuppressive regimen since 1980 resulted in survival rates of 60% 
70% at one year in patients that were operated by Starzl and associates 2 
Most liver transplantation groups perform orthotopic liver transplantation 
in which case the damaged liver is removed and replaced by a transplant. 
There are many liver diseases for vhich orthotopic liver transplantation 
is performed (Table 1 )3 . End-stage cirrhosis or biliary atresia is the 
indication to perform orthotopic liver transplantation in almost 50% of 
patients reported by the main transplantation groups3. Important 
differences exist among transplantation centers regarding the criteria for 
acceptance or rejection of individual patients. In the Netherlands 
selection criteria for orthotopic liver transplantation are rather 
stringent; only 10% of referred potential candidates for liver 
transplantation with 
transplanted4 Most 
end-stage chronic liver disease were actually 
centers agree that orthotopic liver transplantation 
bears to many risk in patients with acute hepatic failure. This syndrome 
occurs by definition in patients with no previous evidence of liver 
disease, and results in the development of hepatic encephalopathy within 
eight weeks of the onset of illness6 . 
2 
Table 1. Main indications for orthotopic liver transplantation 
Primary hepatic malignancy 
Non~alcoholic ciu-rhosis 
Alcoholic cirrhosis (Abstentia for 1 year) 
Congenital hepatobiliary disorders 
Sclerosing cholangitis 
Hepatic vein thrombosis 
Etiology o£ acute hepatic failure is summarized in Table 2 7 • The absence 
of pre-existing hepatocellular disease is an important component of the 
definition of acute hepatic failure. since it implies that hepatic 
structure and function could return to normal, provided that: (1) the 
pathogenetic factor responsible for fulminant hepatic failure could be 
removed or inactivated; (2) the functions of the failing liver could be 
adequately replaced; and (3) the liver retains its capacity to 
regenerate. In the absence of an effective artificial liver support 
system mortality is 80% in these patients with acute hepatic £ailure 
despite a£ intensive care treatment8 •9 . The £requency o£ acute liver 
£ailure caused by dif£erent etiology is not exactly known but is estimated 
to be 2000 per year in the United States 10 . 
Table 2. Etiology of fulminant failure. 
Viral hepatitis (A,B, and non-A, non-B) 
Other viral infections (Epstein Barr, adeno virus, herpes) 
Yellow fever 
Coxiella burneti 
Amanitia phalloides 
Drugs (acetaminophen, isoniazid) 
Hepatic ischemia 
Pregnancy associated 
Reye's syndrome 
3 
Although liver transplantation is obviously indicated in patients with 
acute hepatic failure, the major transplantation groups to date have been 
reluctant to perform orthotopic liver transplantation in the case of acute 
hepatic insufficiency. The poor clinical condition of these patients and 
the associated clotting disorders form too great a risk for succesful 
removal of the diseased liver and replacement by a donor organ. 
Patients with acute hepatic failure or with end-stage chronic liver 
disease that are not accepted for orthotopic liver transplantation might 
benefit from auxiliary liver transplantation. 
1.2 Aim of auxiliary liver transplantation 
In auxiliary liver transplantation, a liver is transplanted without the 
removal of the recipient's own liver. 
Indications to perform auxiliary liver transplantation theoretically are 
the same as in orthotopic liver transplantation (Table 1 ). The only 
exception is primary malignancy in the recipient liver where auxiliary 
liver transplantation obviously is not a realistic solution for the 
patient. 
Long-term survival incidentally has been described after auxiliary liver 
transplantation 11 • 12 . However, as initial clinical results with auxiliary 
liver transplantation were discouraging 
technique in favor of orthotopic liver 
most centers abandoned this 
transplantation13 . Still the 
concept of auxiliary heterotopic liver transplantation in non-neoplastic 
diseases remains attractive. 
Compared with orthotopic liver transplantation the auxiliary technique has 
the following potential advantages. 
Limited extent oT the procedure. Transplantation without removal of the 
diseased recipient liver could have 
critically ill recipient the additional 
complications of hepatectomy14 . 
the advantage of sparing the 
operation time and potential 
Temporary metabolic support. In potential reversible liver disease 
auxiliary liver transplantation could help to keep the patient alive 
during the 
the event 
time required for the patient's own liver to 
of adequate regeneration and recovery of 
regenerate. In 
function of the 
patient's own 
removed15 • 16 . 
liver the auxiliary graft could, theoretically, be 
Should the host's liver not recover, the graft could serve 
as a permanent replacement12 . 
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Residual capacity of the recipient's liver. In auxiliary liver 
transplantation the patient's own liver could provide some protection for 
the patient during the period of establishment of graft function, and 
during rejection periods11 . The recipient's own liver is maintained as a 
functional reserve in case the donor liver does not function well. 
Stimulation of regeneration in the recipient's liver by the graft Total 
and partial auxiliary liver transplants 
regeneration of the recipient's liver 17 . 
produce a factor that stimulates 
This factor responsible for the 
initiation and stimulation of hepatic regeneration has recently been 
characterized and partially purifiect18 . 
1.3 Results of clinical auxiliary liver transplantation 
The first auxiliary liver transplantation in man was performed in 1964 19 . 
Only a limited number of such operations have been performed in the United 
States and Europe since11 • Indications for which heterotopic auxiliary 
liver transplantation 
;;11 ,20,21,22_ 
were performed in man are listed in Table 
Table 3. Number of patients and indicationsofauxiliarylivertransplants in man. 
Biliary atresia 
Cirrhosis 
Primary malignant tumor 
Acute hepatitis 
ldeopatic cholangiostatic syndrome 
Rejection of orthotopic transplant 
Hepatic failure after extensive liver resection 
Number of patients 
20 
17 
4 
4 
As in orthotopic liver transplantation liver cirrhosis and biliary atresia 
were the main indications for auxiliary liver transplantation in these 
patients. The operation was technically feasible in man but experience so 
far has not been encouraging: of 48 reported cases only two patients have 
survived more than one year, and most patients died within one month. 
Fortner reported a patient still alive more than 10 years after 
transplantation23 , and Bismuth and co-workers recently reported survival 
5 
of 6.5 years after auxiliary liver transplantation20 The indications for 
liver transplantation in these two cases were biliary atresia in a child 
and end-stage cirrhosis in a middle aged man respectively. These two 
patients demonstrate that auxiliary liver transplantation is possible in 
man and justify further evalution of this type of liver transplantation. 
1.4 Problems in clinical auxiliary liver transplantation 
Problems such as preservation of the transplant, reconstruction of the 
biliary tract, immunosuppression, and management o£ infectious 
complications are basically the same in orthotopic liver transplantation 
and auxiliary liver transplantation. Most of these problems have been 
overcome in recent years for the orthotopic technique as reflected by 
improved survival rates2 . Selection of lower risk patients for 
transplantation probably also contributed to these better results. 
The causes of failure of 44 heterotopic auxiliary liver transplants in man 
reported by Fortner are summarized in Table 411 . 
Table 4. Causes of failure in human auxiliary fiver transplantation. 
Sepsis 
Liver failure 
Cardiorespiratory insufficiency 
Hemorrhage 
Hepatic artery thrombosis 
Biliary fistula 
Pneumocystis 
Acute renal failure 
Inanition, monilia 
Number of patients 
12 
10 
7 
6 
5 
1 
1 
1 
One of the problems concerning auxiliary liver transplantation is the size 
of the organ that has to be positioned in the abdominal cavity. The graft 
may cause elevation of the diaphragm and subsequent respiratory 
camp 1 ications. The use of 
frequency of cardiorespiratory 
grafts of reduced size 
insufficiency20 . Leakage 
may diminish the 
of the biliary 
enteric anastomosis resulted in sepsis in a significant number of 
6 
patients. As in orthotopic liver transplantation this anastomosis is a 
potential source of complications13 
It has been suggested that after auxiliary liver transplantation the two 
livers might function in a balanced state24 , with the graft and the 
patient's liver functioning simultaneously and being mutually supportive. 
In a patient with an unresectable liver tumor who survived eight months 
after auxiliary liver transplantation autopsy indicated that a 
physiological balance between the transplant and the host liver indeed had 
been achieved, as the size of the livers appeared to be the same. In that 
patient there was no indication of recipient liver atrophy, although the 
tumor mass in the host liver probably did not contributed to total liver 
function-In clinical auxiliary liver transplantation hypertrophy of the 
graft and atrophy of the recipient liver has been observed in the two 
patients that survived more than five years. Both patients are alive and 
well with no residual host liver function12 •25 . Progressive atrophy of 
recipient liver could be secondary to long-term preferential portal blood 
flow through the graft as suggested by Marchioro25 . Recipient liver 
recovery after an episode of liver failure with atrophy of an auxiliary 
liver graft at the same time, has never been reported in man. 
Development of a primary liver malignancy in the diseased host liver in 
the period following the transplantation procedure is a potential hazard 
in auxiliary liver transplantation. This complication has not been 
reported in the small series of heterotopic liver transplantations so far 
performed in man. 
1.5 Results of experimental auxiliary liver transplantation 
Experimental auxiliary liver transplantation was performed for the first 
time by Welch in 195526 . He demonstrated in the dog that entire livers 
could be transplanted heterotopically and that these livers continued to 
function in the recipient animals. Since this first auxiliary liver 
transplantation extensive experimental work has been performed in this 
field. Research was mainly focussed on the problems of: (1) space; (2) 
position of the graft; (3) blood supply to the graft; 
drainage; and (4) rejection. 
(4) biliary 
The problem of space The placement of a large additional organ into the 
abdominal cavity may prevent closure of the laparotomy wound24 . Forced 
closure results in elevation of the diaphragm causing respiratory 
complications, kinking of the blood vessels of the graft, compression of 
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the host's blood vessels and poor wound healing. Gradual enlargement 
preoperatively of the abdominal cavity24 , removal of other organs such as 
the spleen or a kidney 19 •27 , and transplantation of small or partial 
grafts have been suggested as solutions27 •28 •29 . In clinical auxiliary 
liver transplantation small grafts can only be obtained from children. 
The number of donor livers available from this age group is limited30, 31 . 
Therefore the problem of space appears to be solved most practically if 
only a part of an adult donor liver is used. 
The problem of position. In auxiliary liver transplantation the graft may 
be placed at different sites of the body. Liver transplants have been 
placed in the right and left upper abdomen32 •33 , right and left lower 
abdomen34 •35 , the thoracic cavity36 , the groin37 , and the neck38 . With 
the liver in the orthotopic position, the hepatic veins drain into the 
inferior vena cava in which vessel blood pressure is low and fluctuates 
with respiration39 •40 . Pressure in the inferior vena cava increases 
proportionately with the distance from the right atrium41 • Fluctuations 
in pressure in the inferior vena cava appear to be inversely related to 
the distance from the right atrium42 It has been shown that pressure in 
the inferior vena cava, distal to the renal veins, causes hepatic venous 
outflow obstruction and graft damage40 · 43 •44 . These findings indicate 
that an auxiliary liver graft should drain into the inferior vena cava as 
close to the diaphragm as possible to avoid damage due to outflow 
obstruction. This will preclude extra abdominal auxiliary grafting and 
limits intra abdominal sites to the upper abdomen. 
The oroblem of blood supply to the graft. In its normal position a liver 
has a dual afferent blood supply: hepatic arterial and portal venous. 
Because the transplanted liver lacks collateral arterial blood flow, 
transplantation without hepatic arterial inflow results in hepatic 
infarction. Subsequent liver necrosis will increase the risk of 
infection. Lack of hepatic arterial blood flow may also cause necrosis of 
the common bile duct, resulting in bile leakage. These problems may well 
negate the efforts of those who have in the past attempted auxiliary liver 
transplantation using a portal venous blood supply only4 5• 46 . 
Depriving the liver of portal blood causes atrophy of the liver even if an 
equivalent volume of systemic venous blood is directed through the 
liver 25 •47 •48 . It has been shown conclusively that pancreatic efferent 
venous blood 
integrity of 
contains one or more hepatotropic factors essential for 
the liver 2 5• 49 •50 •51 •52 . These observations 
the 
in 
non-transplanted normal livers seem to indicate that a liver requires both 
an arterial and portal venous blood flow for prevention of ischemic 
complications and atrophy. Starzl and others indeed have shown that 
atrophy rapidly develops in auxiliary liver transplants lacking this dual 
8 
blood su:pply27. 53.54. No long-term survival has been reported in 
hepatectomized dogs with liver transplants receiving arterial blood supply 
only28,55_ 
It thus appears that in auxiliary liver transplantation the graft should 
have an adequate in~low o£ arterial blood, as well as inflow of portal 
venous blood. Anatomically these two anastomoses can be constructed more 
easily in the upper abdomen than in the pelvis or any extra-abdominal 
position. 
The problem of biliary drainage. Bile drainage can be achieved by 
external or internal drainage. External drainage of the biliary system of 
the transplant has been used in some experiments but is a less practical 
solution than internal drainage 16 •28 • 56 . Most authors perform internal 
drainage anastomosing the common bile duct of the graft to the common bile 
duct, the gallbladder, the jejunum or the duodenum of the recipient. 
Drainage into the recipient's ovn distal biliary tract is used 
successfully in orthotopic liver transplantation2 •57 . Calne has developed 
a conduit procedure in which the common bile duct of the graft is 
anastomosed to the gallbladder of 
connected to the recipient bile 
the graft, 
duct 58 . 
which is subsequentely 
In orthotopic liver 
transplantation drainage into the common bile duct of the recipient 
retains drainage through the sphincter of oddi and prevents cholangitis as 
has been demonstrated in animal experiments59 . As the biliary tracts of 
the transplant and the recipient liver are usually separated, drainage 
into the common bile duct of the recipient has not been used frequently in 
The technique of experimental auxiliary liver transplantation. 
cholecysto-jejuno-cholecystostomy as suggested by Crosier is difficult and 
time consuming60 . 
In experimental auxiliary liver transplantation in large animal models, 
cholecystojejunostomy was the technique of biliary anastomosis preferred 
by most authors27 •55 •61 •62 •63 . Animal survival in these forementioned 
studies, however, is too short to evaluate this type of anastomosis in 
auxiliary liver transplantation. In orthotopic liver transplantation 
cholecystojejunostomy appears to be inferior to a direct biliary enteric 
anastomosis64 • 65 . Recent experimental work suggests that in pigs direct 
choledochoduodenostomy and 
successful types of biliary 
anastomosis between the 
Roux-en-Y choledochojejunostomy 
anastomosis41 . In the case of 
are both 
a direct 
intestine and the common bile duct, a 
cholecystectomy of the transplant must be performed, because in the 
absence of a sphincter mechanism the gallbladder acts as a diverticulum of 
the common bile duct which will cause cholangitis65 
9 
The oroblem of rejection. For all types of organ transplants prolonged 
survival of the graft is largely dependent on recognition of rejection and 
the prompt institution of immunosuppressive therapy. In both clinical and 
experimental liver transplantation the early detection of rejection, as 
well as its distinction from cholangitis, cholestasis other 
complications has remained a problem66 •67 •6B, 69. 
The presence of two livers in auxiliary transplantation complicates the 
problem of early diagnosis of rejection. The recipient's own liver may 
modify clinical symptoms and biochemical or haematological results and may 
complicate assessment of graft function. 
that reflects specifically the status 
No single 
of the 
biochemical test exist 
graft. Histological 
examination of sequential percutaneous liver biopsies of the graft is the 
only procedure that may correctely indicate graft rejection. 
Clinical and experimental orthotopic liver transplantation studies have 
demonstrated that rejection is a less serious problem compared to 
rejection encountered in kidney transplantation70 •71 •72 . Donor-recipient 
selection based on tissue-typing appears to be less important. It is not 
clear if the same holds true in auxiliary liver transplantation. The 
presence of the recipient liver may modify the rejection process46 Liver 
allografts have been reported to be spontaneously tolerated in the rat and 
the pig but only after total removal of the recipients' own liver70 •7 3• 74 • 
This suggests that a healthy recipient liver prevents the induction of a 
-donor-specific transplantation tolerance- following auxiliary liver 
transplantation. It has also been shown that the reticulo-endothelial 
system of the liver participates in graft rejection46 . In the case of a 
severely diseased host liver with impaired reticulo-endothelial function 
the immunological attack on the graft might therefore be less. 
In experimental auxiliary liver transplantation either no 
immunosuppressive therapy has been given or a combination of azathioprine 
and steroids has been used33 • 59 •76 . Information about the effect of new 
immunosuppressive regimens with Cyclosporin A on experimental auxiliary 
liver graft survival is not available. 
10 
The foregoing results on experimental auxiliary liver transplantation 
enables one to propose theoretical criteria for optimum function of an 
auxiliary liver transplant: (1) the donor liver should be small or only a 
part of a donor liver should be used; (2) the graft should drain into the 
inferior vena cava as close to the diaphragm as possible; (3) the graft 
should have inflow of arte~ial blood as well as portal venous blood; and 
(4) the graft should have a direct anastomosis between the common bile 
duct of the graft and the duodenum or jejunum of the recipient. 
1.6 Objectives of the stu~ 
In the following chapters studies in dogs and pigs are described. The 
aims of these experiments were: 
1. To develop a surgical technique of partial auxiliary liver 
transplantation in ~hich all requirements for optimal graft 
function ~ere met (chapter 2, and 3). 
2. To study the effect of tissue-typing in that model (chapter 2, 
and 3). 
3. To develop a model o£ acute liver £ailure (chapter 4). 
4. To study the metabolic support o£ an auxiliary partial liver 
transplant in that model o£ acute liver £ailure (chapter 5). 
5. To study technical £easibility, hemodynamic changes, and clotting 
abnormalities in auxiliary partial liver transplantation in the 
presence o£ acute hepatic £ailure (chapter 6). 
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CHAPTER 2 
First experiment 
LONG-TERM SURVIVAL OF AUXILIARY PARTIAL LIVER GRAFTS IN DLA-IDENTICAL 
LITTERMATE BEAGLES 1 
1This chapter has been published before in Transplantation 1985; 39: 113 
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Auxiliary heterotopic tr~~splantation o£ 60% of the liver in the beagle, 
using a technique in which all requirements for optimal graft survival are 
met is described.The autologous liver is left in situ . Transplants were 
performed in both non-tissue-typed and matched donor-recipient 
combinations. 
Postoperatively the recipients were treated with a standard schedule of 
two mg azathioprine and one mg prednisolone intravenously daily for 75 
days, thereafter the immunosuppressive drugs were gradually withdrawn. 
HIDA-hepatobiliary scanning proved to be useful for the assessment of 
graft function. 
In eight non-tissue-typed donor-recipient combinations median graft 
survival was 7 days , most transplants being subject to acute rejection. 
However,in nine experiments where donor and recipient were DLA-identical 
littermates, the median graft survival was 112 days (p<0.005). In these 
animals signs of chronic rejection developed a£ter tapering off the 
immunosuppressive drugs. 
It is concluded that in this model graft survival is improved by 
histocompatibility matching. The feasibility of partial heterotopic liver 
transplantation indicates that this method needs to be reconsidered for 
clinical application, especially for patients with acute liver failure. 
For the recipient it is a relatively minor operation that by its temporary 
life sustaining function may allow for the regeneration or restoration of 
function of the recipient's own liver. 
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Introduction. 
A theoretical advantage of auxiliary liver transplantation is that the 
recipient does not depend at the outset totally on the homograft function. 
In patients with potentially reversible hepatic disease temporary life 
support could be obtained during which recovery of the own liver could be 
awaited. Technical hazards of recipient hepatectomy. especially in the 
case of severe clotting disorders as in acute liver failure, are avoided. 
Despite of these theoretical advantages. results of clinical (1) and 
experimental (2) auxiliary liver 
appeal of transplanting an auxiliary 
superfluous. led us to continue 
model. 
tranplantation have been poor. The 
liver. which can be removed i~ 
to search for a suitable experimental 
Analysis of the reported failures of auxiliary liver transplantation 
revealed the ~allowing problems. 
abdominal cavity after placement of 
compression o~ the transplanted 
1 ) Lack o~ space in the recipient 
a large additional organ results 
liver and its blood vessels (3)-
in 
2) 
Insuf~icient venous out~low o~ the graft leads to venous congestion and 
thrombosis (4). 3) Omitting e~~luent portal blood to the transplanted 
liver causes atrophy o~ the graft (5). 4) Omitting arterial in~low to the 
graft will lead to hepatic infarction and to insufficient blood supply to 
the bile ducts (6). 
Long-term survival o~ grafts after orthotopic liver transplantation in 
DLA-identical beagles has been reported (7), but in orthotopic liver 
transplantation it has been stated that liver allografts are less 
immunogenic than other tissues in organ transplantation (8}. However, 
rejection phenomena comparable to other transplanted tissues have been 
described after auxiliary liver transplantation ( 9). Studies on the 
bene~icial e~~ect of tissue matching on survival of auxiliary liver 
transplants have not been reported previously. 
The present study was aimed at two objectives: 1 ) to evaluate the 
technical ~easibility of auxiliary transplantation o~ a part o~ the liver 
in dogs as to meet the theoretical requirements essential ~or optimal 
graft survival and ~unction and 2) to study the in~luence o~ DLA-tissue 
typing on auxiliary liver graft survival. 
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Material and methods. 
Dogs. In two consecutive series o~ experiments, 24 heterotopic auxiliary 
transplantations o~ part of the liver were carried out in dogs. Beagles 
of both sexes, obtained from the colonies at the Centraal 
Proefdierenbedrijf 
(mean±SEM) served 
TNO, Austerlitz, The Netherlands, weighing 13.0±0.3 kg 
as donors; the recipients weighed 13.7±0.4 kg. 
~atchinq. In the first series of experiments (n~14) the donor and 
recipient were unrelated and not tissue-typed for the DLA system (group A) 
but in the second group (n=10) donor and recipient were DLA-identical 
littermates (group B). DLA-identity was established by means of both 
serological typing and mixed lymphocyte reaction as described previously 
(10,11). 
Donor operation. Hepatectomy vas pe~formed using a long midline incision. 
Peritoneal attachments of the liver and inferior vena cava to the 
posterior abdominal wall were divided. The portal vein, common bile duct 
and hepatic artery were dissected. The hepatic artery was carefully 
isolated and the origin of other arteries of the coeliac axis were 
individually ligated. The gastrohepatic, triangular and the falciform 
ligaments were divided. Following exsanguination of the donor animal the 
liver was perfused in situ through the portal vein with one litre of 
• 
cooled Eurocollins solution (4 C). The hepatic artery was flushed with 
20 ml of the same solution. Thereafter, the graft was prepared by bench 
surgery. A cholecystectomy was carried out and a small polyethylene tube 
was inserted into the cystic duct to enable cholangiography after 
transplantation for follow-up studies. The two left lateral lobes were 
resected, reducing the weight of the donor liver to 58.4±1.8% of the 
original weight (mean±SEM). 
Recipient operation. During bench surgery another team started operating 
on the recipient animal. Through an extended right subcostal incision the 
infrahepatic vena cava, the portal vein and the infrarenal aorta were 
dissected. Then the suprahepatic vena cava of the graft was anastomosed 
to the recipient infrahepatic vena cava as close to the diaphragm as 
possible, proximal to the renal veins, using a running 5-0 prolene suture. 
After evacuation of Eurocollins by flushing of the donor liver with 500 ml 
saline, the portal vein of the graft was anastomosed (with 6-0 prolene) 
end-to-side to the host portal vein. On completion of the anastomosis the 
portal venous clamp was removed allowing perfusion of the graft and ending 
the ischaemic period. The infrahepatic part of the donor vena cava was 
ligated. A shunt for temporary decompression of the splanchnic 
circulation during portal clamping was not necessary. The recipient 
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portal vein was ligated and divided between ligatures close to the liver 
hilum. The hepatic artery with an oval aorta patch was anastomosed 
end-to-side to the infrarenal aorta using 5-0 prolene. Bile drainage was 
obtained by choledochoduodenostomy by pulling the common bile duct through 
a stab wound in the duodenum and securing it to the inner wall of the 
bowel with a single 
recirculation of the 
4-0 catgut suture (Fig.1 ). Immediately after 
graft 400 ml of HaemaccelR was given intravenously. 
Blood loss exceeding 300 ml was corrected by administration of an equal 
amount of blood from the donor animal. 
Antibiotic prophylaxis with 15 mg lincomycine and 15 mg kanamycine per kg 
body weight twice daily was given for five days a£ter the operation. 
Fig. 1 . Diagram of the surgical technique of auxiliary partial liver 
transplantation. 
Immunosuppression. All animals received two mg azathioprine and one mg 
prednisolone per kg body weight intravenously once daily starting at the 
end of the operation. The immunosuppressive medication was continued 
until the 75th postoperative day; thereafter the dosage of the drugs was 
tapered off gradually 
count dropped below 
discontinued. 
until the 150th postoperative day. If the platelet 
50x10 9/l, azathioprine medication was temporarily 
Postoperative studies. Weekly blood samples served to determine 
haemoglobin, leucocytes and platelets. Serum alkaline phosphatase. 
glutamic oxalacetic transaminase,glutamic pyruvic transaminase. lactic 
dehydrogenase and gamma glutamyl transaminase were measured. 
Intravenous angiography as described previously (12) was performed at the 
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fourth postoperative day to visualize the arterial and portal anastomoses. 
During this procedure a cholangiography of the donor liver was done to 
exclude stenosis of the choledochoduodenostomy and to detect bile leakage. 
During the second series of experiments a gamma camera became available 
and graft function could then be assessed at monthly intervals after the 
operation bY cholescintigraphy. After intravenous injection of 55.5 
MBq99mTc-HIDA scintigraphy was performed with a Pho Gamma-III camera 
(Siemens, Gammasonics) with a low energy all purpose collimator. 
Histology. At operation and at autopsy wedge liver biopsies were taken. 
Sequential liver biopsies were obtained with a Tru-cutR biopsy needle in 
the second post operative week and monthly thereafter. The tissues were 
fixed in 10% buffered formalin and 5~ paraffin embedded sections were 
stained with hematoxylin azophloxin and saffron. Examinations of the 
liver biopsies were performed on a blind observer basis. An assessment 
was made of the presence and degree of cholangitis. cholestasis. 
hepatocellular necrosis and rejection as estimated by the degree of 
periportal lympho-plasma cellular infiltration. bile duct proliferation 
and vasculitis. 
Graft survival was assessed by sequential histopathological studies. 
visualization of the anastomoses and intrahepatic branches at angiography 
and by cholescintigraphy. Surviving animals were sacrificed 182 days 
after the operation or sooner as indicated by clinical condition. Graft 
survival data were analyzed statistically by means of one sided Wilcoxon 
rank sum tests. 
Results. 
Early mortality. No death occurred intraoperatively. In group A (n=14) 
four dogs died within one week after the operation of technical failures 
(intra-abdominal hemorrhage. thrombosis at the portal vein and hepatic 
artery anastomosis). Two other dogs died of unknown causes four and five 
days after the operation. At autopsy their grafts had a normal appearance 
and histological examination showed normal liver tissue. The remaining 
eight dogs provide the data for analysis of graft survival in the 
non-tissue-typed experiments. 
In group B (n=10) one dog died of bile peritonitis caused by puncture of 
the gall bladder during a percutaneous liver biopsy, 14 days after the 
transplantation. Histology of the liver graft in this animal was normal. 
This dog is excluded from the further analysis. 
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Table 1. Animal and liver allograft survival in eight non-tissue-typed beagles (group A) 
Vascular anastomoses at autopsy--
Dog Survival Graft Gause of death Histological findings Vena Portal Hepatic 
No. {days) survival in graft cava vein artery 
(days) 
1 8 4 Graft necrosis Acute rejection Oo Oo p 
2 12 7 Graft necrosis Total necrosis Oo p p 
3 88 42 Sacrificed in Graft resorbed Oo Oo Oo 
good health 
4 55 14 Sacrificed in Acute reJection p Oo p 
poor condition 
5 28 7 Sacrificed in Total necrosis Oo Oo Oo 
poor condition 
6 13 4 Graft necrosis Acute rejection Oo Oo Oo 
7 182 112 Sacrificed In Chronic rejection p p p 
good health 
8 18 7 Graft necrosis Acute rejection p p p 
M0dian 23 7 
value 
.. Oc :::=occluded, P :::= patent 
Survival. The median animal survival in group A Yas 23 days (Table 1 ). 
Most animals died or were sacrificed in poor condition caused Oy graft 
necrosis. The deterioration in the clinical condition was accompanied by 
anemia,leukocytosis and thrombocytopenia. Only two dogs remained in good 
clinical condition until time of sacrifice on days 98 and 182 after the 
operation. 
In group B the median animal survival was 182 days (Table 2). Only two 
beagles were sacrificed before the end of the observation period because 
of intraabdominal abscesses in and around the liver graft. Average body 
weight in these animals diminished to a 92% of preoperative values in the 
first four weeks following operation but body weight was regained 
thereafter. In contrast to the first experimental group, the hemoglobin 
and blood platelet levels remained in the normal range. The initial rise 
in white blood cell count returned to normal values within three weeks 
after the operation. 
Five animals in each group received a blood transfusion during surgery 
with blood from the donor animal. 
Graft survival. Estimated median graft survival in the non-tissue-typed 
donor-recipient combinations was 7 days (Table 1 ), but in the dogs that 
received a DLA-identical liver transplant median graft survival was 112 
days (Table 2). 
(p<0-005). 
This difference in graft survival time is significant 
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Table 2. Animal and liver allograft survival in nine DLA~identical littermate beagles (group B) 
vascular anastomoses at autopsy-
Dog Survival Graft Cause of death Histological Vena Portal Hepatic 
No. (days) survival findings In graft cava vein artery 
(days) 
182 112 Sacrificed in good Chronic reJection p p p 
health 
2 182 182 Sacrificed in good Minimal chronic p p p 
health rejection 
3 182 42 Sacrificed in good Chronic rejection p Oc Oc 
health 
4 182 56 Sacrificed in good Chronic reJection p p p 
health 
5 154 35 Sacrlficod. abdominal Chronic rejection Oc Oc p 
abscess 
6 77 14 Sacrificed. abdominal Chronic reJection p Oc p 
abscess 
7 182 182 Sacrificed in good Minimal chronic p p p 
health rejection 
8 182 140 Sacrificed in good Chronic rejection p p p 
health 
9 182 182 Sacrificed in good Minimal chronic p p p 
health rejection 
Median 182 112 
value 
• Oc =occluded, P = patent. 
Biochemistry. In group A transaminase and serum lactic dehydrogenase 
levels rose to high values in the first month after transplantation. Most 
levels tended to normalize thereafter in all animals. In the two dogs 
that survived for more than eight weeks, normal values were reached in the 
end. Serum alkaline phosphatase concentration remained significantly 
elevated during follow-up period in all dogs. 
In group B serum levels of transaminase ,lactic dehydrogenase and alkaline 
phosphatase were increased in all recipients following the operation. 
Although restoration to normal was observed in some animals, in others 
levels remained elevated throughout the experiment whether or not 
rejection was prominent. 
Angiography. Intravenous angiography four days after transplantation was 
performed in five beagles in group A. The hepatic artery of the graft 
could be visualized in all cases and no stenosis was detected. The portal 
vein was depicted in three animals. 
In group B seven 
artery of the 
dogs underwent intravenous angiography. The hepatic 
donor liver was patent in all cases while the portal vein 
was visualized in five dogs. 
Cholangiography. Eleven animals underwent an additional cholangiography 
of the graft. In both groups one animal showed some leakage of the 
contrast material at the choledochoduodenostomy. At autopsy leakage of 
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saline injected through the bile duct cannula could not be demonstrated in 
these two animals. In the other dogs in both groups the 
choledochoduodenostomy was patent without stenosis or leakage. 
Cholescintigraphy. Scintigraphy facilities were not available in group A. 
In all animals with a DLA-matched transplant (group B) HIDA-hepatobiliary 
scintigraphy was performed. Three grafts showed normal uptake of the 
isotope in the liver and excretion into the duodenum; at autopsy these 
dogs had vital grafts. In two dogs the liver grafts were able to 
concentrate the radiopharmacon but excretion into the bile system was poor 
or absent. Scintigraphy showed no graft function in the remaining four 
animals. All recipient livers could be visualized separately and had 
normal uptake and excretion 
Histopathological Findings. 
of the surgical procedure, 
consisting of degeneration of 
In group A graft biopsies, taken at the end 
sho~ed minimal changes in the parenchyma 
groups of hepatocytes. Architecture of 
liver parenchyma remained intact until necrosis of grafts occurred. One 
transplant under~ent subtotal necrosis in the second postoperative week 
(Table 1 ). In five beagles total graft necrosis developed within two 
weeks. In the other two animals one graft was completely resorbed 12 
weeks after the operation, while the other showed an estimated 60% 
necrosis at sacrifice 182 days after transplantation. In four grafts in 
this group, acute rejection was demonstrated, characterized by vasculitis 
and polymorph nuclear infiltration in the portal triads. One donor liver 
showed chronic cholangiolitis with infiltration of the ductuli by lymphoid 
cells. Cholestasis was absent in the histopathological slides of the 
grafts. 
Histopathological studies in group B showed a differe~t picture. In three 
recipients the grafts demonstrated normal hepatocytes with necrosis of 
less than five percent at the end of the experiment. These three 
transplants showed only minor signs of chronic rejection characterized by 
round cellular infiltration in portal triads pseudo-bile-duct 
proliferation. Chronic graft rejection resulting in total necrosis of 
liver parenchyma occurred in four animals (Table 2). In one dog chronic 
rejection resulted in necrosis of an estimated 50% of hepatocytes at 
sacrifice. In three transplanted livers in this group signs of ascending 
cholangitis resulting in early biliary fibrosis were seen. Only one of 
these animals had a stenosis at the choledochoduodenostomy at autopsy. 
The recipient livers in both groups showed no gross abnormalities in liver 
architecture and parenchyma. 
Autopsy Findings. Jaundice and ascites were absent in all animals at 
autopsy. 
all cases. 
The recipient livers were normal at macroscopic inspection in 
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In group A the donor liver was enlarged and congested in four dogs; these 
animals had died within three weeks after transplantation. The other 
grafts appeared to be small and partially necrotic, with multiple 
abscesses in one case. One liver graft was totally resorbed and no 
remnant could be found. In two animals all the vascular anastomoses were 
patent; in the other dogs one or more were occluded at autopsy (Table 1 ). 
In group B wet weight of the graft had decreased in eight dogs bY 
53.3±10.9% (mean±SEM) compared with operative values; in one recipient. 
however, the graft increased in size by 67.8%. The grafts were usually 
firm and in two dogs abscesses in the transplanted liver were seen. At 
the choledochoduodenostomy stenosis had occurred in two cases although 
dilation of the bile duct was only seen once. In six dogs patency of all 
vascular anastomoses was demonstrated (Table 2). 
Discussion. 
The results of this study demonstrate 
grafting in the dog can be performed 
technical problems. The right subhepatic 
transplant consisting of 60% of the 
that auxiliary partial liver 
without major intraoperative 
space offers enough room for a 
donor liver. At the end of the 
operation the abdomen of the recipient could be closed easily without any 
tension. The bare resection surface of the graft, created after removal 
of the two left lateral lobes, caused some blood loss at the end of the 
operation. Meticulous ligation of all visible vascular and biliary 
structures during bench surgery is essential. 
Most theoretical requirements for well functioning of the graft, as stated 
by others (3-6), are met in this experimental study. Portal venous inflow 
was obtained directly from the portal vein. In the early series acute 
thrombosis of the portal vein, leading to acute death of two recipients, 
may have been caused by slight torsion of the donor portal vein after 
completion of the anastomosis. This complication was avoided during later 
experiments. 
In our model the host portal vein was divided close to the liver hilum to 
ensure optimal portal blood flow through the graft. Although loss of 
portal blood flow through the recipient's own liver resulted in lack of 
so-called -hepatotropic- factors and can lead to atrophy (5), this was not 
apparent in the histopathological examinations in our experiment. In 
recipients with potentially reversible liver disease, the portal vein of 
the host liver needs not to be ligated, because an intrahepatic block, 
29 
present in most cases of chronic and acute liver failure (13), will 
probably ensure portal blood flow through the auxiliary grafts. 
The histology of the dog liver differs from that of man in respect to 
smooth muscular sphincters in the hepatic venules (14). Increased 
vascular resistance in the outflow tract of the graft ascribed to these 
sphincters has been observed by others after auxiliary (15). as well as 
after orthotopic (16). liver transplantation. In our experiments this 
phenomenon of -outflow block- has not occurred once as congestion in the 
graft was never seen at operation. 
The diameter of the common bile duct in the dog is small, 
4-5 mm. We therefore created a choledochoduodenostomy 
not exceeding 
by using the 
pull-through 
(17). Bile 
technique as described in transplantation experiments in rats 
duct obstruction could not be demonstrated early a~ter 
operation on cholangiography. Obstruction probably leading to ascending 
bacterial in~ection was demonstrated in one animal, and grafts in only 
three other dogs showed cholangiolitis without evidence o~ stenosis at the 
biliodigestive anastomosis. There~ore it is concluded that the 
pull-through technique is an adequate method in the dog . 
The presence o~ the healthy liver of the recipient in our 
difficult to diagnose early rejection or dysfunction 
model made it 
of the graft. 
Biochemical and haematological values are not valid as an index o~ graft 
viability. Elevated liver enzym levels indicated ongoing necrosis of 
hepatic tissue as was demonstrated by histological findings. If the enzym 
levels return to normal, necrosis is less apparent or the graft is totally 
resorbed. 
Cholescintigraphy with 99mTc-HIDA is a relatively simple method to assess 
graft function as has been shown in the second series of experiments. 
Graft rejection might also be predicted by this method (18). 
It has been reported that blood transfusions given on the day of 
transplantation may have a beneficial effect on allograft survival 
(19,20). In our experiments an influence of blood transfusions on graft 
survival could not be demonstrated because the number of animals that 
received a blood transfusion was too small for statistical analysis. 
In experimental orthotopic liver transplantation Calne found that liver 
allografts in pigs survived for considerable periods without rejection 
(8). Other investigators concluded that even in the case o~ a 
cross-match-positive 
contrast to these 
donor, hyperacute rejection did not occur (21). 
observations, the auxiliary grafts in 
In 
the 
non-tissue-typed combinations from our study were subject to severe immune 
attack. In the non-tissue-typed group graft survival for longer periods 
occurred only twice; as tissue typing was not performed in that group an 
accidental match between donor and recipient cannot be excluded. 
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It could be argued that operative experience accounts for the difference 
in the survival times of both experimental groups. However, several 
pilot-experiments preceded this study and the procedure of auxiliary liver 
transplantation was well established in our laboratory at the beginning of 
the reported experiments.Total operation time as well as duration of graft 
ischemia did not differ between the two series of experiments. 
Furthermore, the histopathological findings of acute rejection in the 
first group and chronic rejection in the second group provide in our 
opinion sufficient proof that the short-term graft survival time in the 
first group is caused by immunogenetic disparity, similar to that reported 
for kidney allografts and other tissues so far investigated to that 
purpose (22). 
We think, therefore,that for liver transplants in the orthotopic and 
auxiliary position, histocompatibility differences are of key importance 
for the survival of the graft, and that liver tissue transplants obey the 
laws of immunogenetics just as those of other organs do (23,24). This is 
in contrast to findings in orthotopic liver transplantation in other 
models, in which histocompatibility matching seems to be of less 
importance (25,26). 
Gugenheim and co-workers observed long-term graft survival in a non 
compatible ru donor-recipient 
transplantation and excision of the 
combination after 
recipient's own 
heterotopic 
liver (27). 
liver 
The 
contribution of a healthY recipient liver to the whole immune response 
system is still unknown. Even more obscure is the role of a diseased host 
liver in this respect. However, our findings indicate that the presence 
of an intact host liver did not prevent long-term graft survival in 
DLA-matched beagles. 
A partially hepatectomized liver has a stimulatory potential on liver 
regeneration (28), that is effective even when taken from the perfusate of 
an isolated liver. In pigs transplantation of a part of the liver in the 
auxiliary position caused a fourfold increase in the host liver thymidine 
kinase activity (29), but an intact auxiliary transplanted liver caused 
less regeneration in the host liver. In view of these reports some 
regeneration might be expected in the longer-surviving animals in our 
model. We, however, did not observe an increase in size or numerous 
mitotic figures at sacrifice. It is a matter for further study whether 
ligation of the portal vein of the host liver might have prevented 
regeneration. If partial auxiliary liver transplantation indeed proves to 
stimulate regeneration of the autologous liver. then this would be an 
additional argument in support of this method for clinical purposes. 
Histocompatibility matching is of key importance in this model, but for 
clinical purposes grafts that are identical for the antigens of the major 
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histocompatibility complex will almost never be available at short notice. 
It is questionable. however, whether such an identity is relevant for the 
immune-compromised liver failure patient. Furthermore, the use of the new 
immunosuppressant Cyclosporin A has been shown to overrule the effect of 
histocompatibility matching in renal transplant recipients (30), and it 
has improved the results of orthotopic liver transplantation in man (31 ). 
Therefore, further research on this subject may prove to provide practical 
possibilities for auxiliary partial liver grafting in patients with acute 
liver failure or end-stage chronic liver diseases, where orthotopic liver 
transplantation bears too many risks. 
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Abstract 
A technique for auxiliary heterotopic transplantation of 60% of the liver 
has been developed in the pig to study acute and chronic rejection. 
Transplantations were performed in 13 non-tissue-typed donor recipient 
combinations without immunosuppressive medication. Three pigs died in the 
first postoperative week from technical problems. In the remaining ten 
animals acute rejection of the graft was not found, but signs of chronic 
rejection developed in six animals. It is concluded that auxiliary 
partial liver transplantation is technically feasible in the pig. 
Although the auxiliary liver graft is subject to immune attack, long-term 
graft survival without immunosuppressive medication can be achieved. 
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Introduction 
Auxiliary liver transplantation has not met with wide acceptance for the 
treatment of hepatic failure. Although the method is attractive because 
it avoids the necessity of removing the patient's own liver, the problems 
associated with the large size of the transplant and the considerable 
technical difficulty of establishing a satisfactory vascular circuit have 
so far limited its use. 
Results of experiments in the dog as described previously indicated that 
auxiliary partial liver transplantation is technically and physiologically 
feasible in beagles. If 60% of a donor liver is transplanted auxiliary 
into the right upper abdomen and provided with portal venous and arterial 
blood, dogs survive for prolonged periods of time with vital grafts (18). 
In spite of considerable research on liver transplantation in the dog 
(16,20,22,6), this animal does not provide the ideal model for liver 
transplantation experiments. The anatomy of the dog liver differs from 
the human liver both macroscopically and microscopically: the lobes of 
the dog liver are well defined and separated by deep clefts. Resection of 
liver lobes aimed at decreasing the size of the graft, therefore, is easy 
in the dog, but less comparable to the human situation. Furthermore, 
sphincters are present around the liver venulae in the dog (5), and are 
absent in man. 
Advantages of the use of the pig as laboratory animal in liver 
transplantation experiments include the similarity of the pig liver to the 
human liver with regard to the macroscopic and microscopic structure, the 
large size of the blood vessels facilitating hemodialysis and studies on 
extracorporeal hepatic support systems as therapy for ischemic liver 
disease (9), and the lower costs of purchasing the animal. 
Our study was carried out to evaluate the feasibility of auxiliary partial 
liver transplantation in the pig and to assess the severity of rejection 
in auxiliary liver transplants in pigs, not tissue typed for the major 
histocompatibility system. 
Material and Methods 
Pigs. Female Yorkshire pigs, commercially obtained from one farm were 
used, weighing 28.5±0.9 kg (mean±SEM). Weights of donor and recipient 
animals were similar. Donors and recipients were not tissue typed for the 
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major histocompatibility system. 
donor-recipient combinations. 
Transplantation was performed in 13 
Surgical technique. Donor hepatectomy was performed using a conventional 
technique. The donor liver 
cannulation with 1 L Euro-Collins 
was perfused ex vivo 
(4 °c). During bench 
by portal 
surgery the 
vein 
two 
left lateral lobes of the liver were resected. All vascular and biliary 
structures in the plane of resection were carefully ligated. In addition. 
the raw liver surface was compressed by a continuous suture with 
atraumatic 2-0 Polydiaxanon (Ethicon R). 
The recipient procedure was started by introducing a polyethylene catheter 
into the internal jugular vein for fluid administration and blood sampling 
during operation. The catheter was passed subcutaneously to the back of 
the pig and exteriorized, facilitating postoperative blood sampling. In 
the first seven animals a Scribner shunt between carotid artery and 
external jugular vein was inserted as well, serving the same purpose. 
The graft was transferred into the recipient's right subhepatic space, and 
the following anastomoses were made: an end-to-side anastomosis between 
the donor suprahepatic vena cava and the recipient subhepatic vena cava, 
and an end-to-side anastomosis between the donor portal vein and the host 
portal vein, followed by ligation of the recipient portal vein in the 
liver hilum, rerouting the splanchnic blood flow through the graft. No 
Host 
liver 
~od 
Fig. 1 . Technique of auxiliary partial liver transplantation. 
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porto-systemic decompression shunt was used. The surgical procedure was 
completed by an end-to-side anastomosis between the donor hepatic artery 
and the aorta o~ the recipient, and an end-to-side choledochoduodenostomy 
(£ig.1 ). In two pigs the host common bile duct was ligated and cut 
between ligatures as an additional procedure to cause hepatic injury in 
the host liver. 
No immunosuppressive medication was used in these experiments. 
Postoperative studies. Hemoglobin, platelets leukocytes were 
determined weekly. Serum glutamic-oxaloacetic transaminase (SGOT), gamma 
glutamyl transaminase, and serum bilirubin were measured weekly. 
Intravenous angiography by 
was performed in the 
the same technique as described previously 
first week after surgery. Patency of 
biliodigestive anastomosis was investigated by cholangiography. 
( 1 ) 
the 
99mTc-HIDA scanning under general anesthesia was performed in pigs 
surviving for at least four weeks. A Pho Gamma-III camera {Siemens, 
Gammasonics) with a low energy all purpose collimator assessed the uptake 
of the radiopharmacon after intravenous injection of 111 MBq 99mTc-HIDA. 
Liver biopsies of host liver and the transplant were taken at surgery 
immediately after revascularization of the graft, in the first 
postoperative week, and at autopsy. All histological specimens were 
examined by the same pathologist on a blind observer basis. Cholestasis, 
cholangitis, vasculitis and inflammatory infiltrates of round cells and 
polymorphonuclear leukocytes were graded as being absent, mild, moderate, 
or severe. The degree of hepatocellular necrosis vas estimated. Acute 
rejection was assessed by the degree of vasculitis. while chronic 
rejection was estimated by the degree of periportal inflammatory 
lymphoplasma cellular infiltrates and pseudo bile duct proliferation. 
Graft survival vas estimated by histopathological findings, 
cholescintigraphy, and angiography. 
DNA and RNA content of the transplant at operation and at sacrifice was 
determined by using the method of Scott et al. (19). 
As no alterations occurred in the clinical condition of those animals 
surviving for more than one month. an average one month observation period 
vas taken as the cutoff point of follow-up. At the end of the experiment 
the animals were killed, or earlier as indicated by the clinical 
condition. 
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Results 
Operative results and mortality. All animals recovered well from the 
surgical procedure. After resection of the two left lateral lobes the 
graft consisted of 61 .2±2-3% (mean±SEM) of the original liver weight. 
Total ischemic time of the transplanted liver was on average 140 min with 
a mean warm ischemia time of 57 min. The portal vein was occluded during 
14 min. All grafts regained a normal color rapidly after recirculation. 
Closing of the abdomen was possible without tension in all pigs. The mean 
loss of blood during transplantation was 480 ml. Transfusion of 400 ml 
blood from the donor animal was given during surgery. 
Postoperative course. Three pigs died in the first postoperative week. 
One death was caused 
d~sconnected Scribner shunt. 
by arterial bleeding £rom an 
The other t~o pigs died £rom 
through the central venous line. 
accidentally 
air embolism 
Table L Animal survival, graft survival, and histological findings at autopsy 
in pigs after auxiliary partial liver transplantation. 
Pig Survival Graft Hepatocellular Cholangiolitis Inflammatory 
No. (days) survival necrosis infiltrations 
(days) 
1 9 9 0 0 +. L 
2 18 18 0 0 0 
3 62 62 0 + +. L 
4 8 8 0 + ++, p 
5 42 7 ++++ impossible to assess 
6 25 25 0 0 +, L 
7 33 7 +++ ++ +++, L 
8 36 14 +++ + ++, L,P 
9 30 4 ++++ impossible to assess 
10 26 26 ++ ++ +++, L 
0 = absent; + = mild; ++ = moderate; +++ = severe; ++++=total necrosis; 
L = lymphoplasmacellular infiltration; P =polymorphonuclear infiltration 
predominant; L, P = mixed cellular infiltration. 
Survival time in the remaining ten animals is depicted in Table I. Median 
animal survival ~as 28 days. In both pigs with ligation o£ the host 
common bile duct, in£ectious complications contributed to death. Autopsy 
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revealed very dilated bile ducts, and biopsies showed cholangiolitis, 
cholangitis, and an inflammatory infiltrate of polymorphonuclear 
leukocytes throughout the host liver parenchyma. 
Two pigs died 9 and 26 days after operation of intestinal strangulation 
and pneumonia respectively. Two animals had to be killed because of 
deteriorating clinical condition; in one case this was caused by graft 
necrosis while the other pig had bilateral pneumonia. Four pigs were 
killed in excellent condition. 
Biochemistry. The hemoglobin content in the first postoperative week did 
not change from preoperative levels. Only in two pigs anemia, occurred two 
and four weeks postoperatively. Leukocyte counts rose immediately after 
transplantation to a maximum of 26 x 10 9;1 (normal values 15±5 x 109/L). 
In the week following surgery the values returned to normal. Platelet 
counts did not change significantly after surgery. Serum transaminase 
levels were elevated in most animals during follow-up studies. In the 
first postoperative week three to four times normal values were reached 
that tended to normalize thereafter. Serum bilirubin was elevated in one 
of the pigs with ligated common bile duct. but remained normal in the 
other animals. 
Angiography. In eight of the nine animals that underwent intravenous 
angiography one week after surgery. visualization of the hepatic artery of 
the graft was obtained without signs of stenosis in seven animals. In one 
pig stenosis at the site of the anastomosis of the hepatic artery and the 
aorta was followed by occlusion of the hepatic artery as proven at 
autopsy. In one animal the hepatic artery was not detectable on the 
intravenous angiogram. although it was found to be patent at autopsy two 
days later. The portal vein was visualized in six cases. In the other 
pigs patency of the portoportal anastomosis was demonstrated at autopsy in 
three; in one animal. however. the portal anastomosis revealed no 
abnormalities but the intrahepatic branches of the portal vein were 
occluded by thrombi. 
Cholangiography. By injection of contrast medium through the cannula in 
the cystic duct of the graft cholangiography was performed in nine pigs. 
No leakage or stenosis was observed at the choledochoduodenostomy. 
Passage of contrast medium into the duodenum was shown in all cases. 
Cholescintigrophy. Hepatobiliary scanning was performed in four pigs at 
one month and in one pig two months after surgery. The other five pigs 
died before a scintigram could be made. Uptake of the radiopharmacon by 
the graft was excellent or fair in three cases and absent in two animals. 
Autopsy. however, revealed patent vascular anastomoses and branches in the 
grafts of these two latter pigs. Excretion of the radiopharmacon into the 
duodenum was excellent in only one animal. 
Histology and autopsy findings. Graft specimens that 
recirculation did show only mild histological 
postoperatively a percutaneous needle biopsy was taken 
were taken after 
changes. One week 
from the grafts. 
Inflammatory infiltration of vessel walls and cholestasis were minor or 
absent in these biopsies. Only one specimen showed almost complete 
necrosis of liver tissue. Acute rejection as indicated by vasculitis was 
absent at this stage of the experiment. In three pigs inflammatory 
infiltrates of both round cells and polymorphonuclear leukocytes could be 
seen ranging from moderate to severe. 
At autopsy the macroscopic appearance of all host livers was normal except 
in the two cases of common bile duct ligation (pigs no.2 and 4) where 
gross dilation of extrahepatic bile ducts was present. Ligation of the 
host common bile duct caused 
In the 
severe cholangitis and extensive 
hepatocellular necrosis. other host livers histological 
examination did not reveal major changes. and cholestasis was absent. 
At autopsy signs of chronic rejection in liver transplants as indicated by 
the degree of lymphoplasma cellular infiltration (Table I). could be 
demonstrated in six animals ranging from mild (fig.2) to severe (fig.3). 
In two pigs the degree of cholangitis and cellular infiltration could not 
be estimated because total graft necrosis existed. In the pig that died 
18 days after transplantation with a ligated host common bile duct. the 
transplant appeared to be completely normal without any sign of rejection 
at all. Different degrees of cholangitis were present in almost all 
grafts at autopsy, although cholestasis was not prominent. 
In only two pigs (no.5 and 9) occlusion of graft vessels had occurred in 
the follow-up period resulting in total graft necrosis. All other 
vascular anastomoses and graft vessels were patent at autopsy. Two pigs 
(no.1 and 4) died from intestinal strangulation and septicemia, but their 
grafts at autopsy were normal both macroscopically and microscopically. 
Graft survival. Estimated graft survival as compared with animal survival 
and histological findings at autopsy is depicted in Table I. The wet 
weight of the liver transplant at autopsy had increased 56.1±18.1% 
(mean±SEM) when compared with operative values in six pigs. Increase in 
wet weight of the liver transplant correlated well with the viability of 
the graft. Decrease of the transplant liver wet weight in the other 
animals was 32.0±9-9%. Median graft survival was 11.5 days (range 4-62 
days). 
Nucleic acids. DNA and RNA contents of liver grafts at operation and at 
sacrifice were calculated in the three transplants surviving more than 25 
days. In these 
increased with 
allografts the total DNA and RNA 
50.3±28.0% and 33.3±18.7% 
regeneration of the graft liver tissue. 
content of 
respectively, 
the liver 
indicating 
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Fig. 2. Graft biopsy specimen at autopsy 62 days after transplantation. 
Mild lymphoplasma cellular infiltration is present, HE, x60. 
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Fig. 3. Severe plasmacellular infiltration in graft biopsy 26 days after 
transplantation. HE. x60. 
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Discussion 
Orthotopic liver transplantation in patients with fulminant hepatic 
failure is rarely successful because of massive intraoperative bleeding, 
postoperative cardiorespiratory failure. and 
suitable alternative procedure for such 
fulminant sepsis (17). A 
patients is auxiliary liver 
transplantation. However, experience with auxiliary liver transplantation 
has so far not been encouraging: of 52 reported cases only two patients 
have survived for more than 5 years (15,8). The main technical difficulty 
in heterotopic intraabdominal liver grafting in clinical and experimental 
studies seems to be the problem of space in the abdomen of the recipient 
(2). Crosier and co-workers demonstrated that auxiliary transplantation 
of the whole liver is technically feasible in the pig, if the body weight 
of the donor animal is about half the weight of the recipient (4). Our 
results indicate that auxiliary transplantation of part of the liver 
reducing the problem of space is successful. Furthermore, the partially 
hepatectomized liver releases regeneration stimulating substances (14). 
In the presence of a diseased host liver the partial liver transplant 
might thus help to induce regeneration in the host liver. 
Portal inflow and a caval implantation of the graft as close as possible 
to the heart to ensure a low outflow pressure are essential for long-term 
graft function (12,13). These two technical requirements were established 
in our study. 
In both experimental and clinical liver transplantations there has been a 
high incidence of serious and fatal complications arising directly from 
the reconstruction of the biliary tract (21 ,23). Many techniques have 
been invented to resolve this problem. In our experiment no serious 
complications could be detected after reconstruction of the biliary tract 
by end-to-side choledochoduodenostomy. This favorable outcome is probably 
the result of anastomosing a distal part of the duct that has an adequate 
blood supply; in our opinion it is mandatory to shorten the bile duct 
till it bleeds before performing the biliodigestive anastomosis. 
In two pigs the host common bile duct was ligated to impair host liver 
function. In both cases serious complications were seen in the 
postoperative period. Although others have successfully used this 
technique in different species to place the graft in a favorable position 
(10,11 ), septic complications are probable, and we abandoned this 
procedure. 
Relative disadvantages of the use 
consist of difficulty in blood 
of the pig as experimental animal 
sampling by venipuncture and the high 
incidence of pulmonary infection as reported after liver transplantation 
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in this animal (24). 
Introduction of a Scribner shunt to circumvent problems in obtaining blood 
samples resulted in accidental bleeding and death of one pig in the 
postoperative period, although the shunt was placed under a specially 
designed jacket. In the first days after transplantation shunt occlusion 
occurred frequently and, therefore, the Scribner shunt as a vascular 
access was no longer used in the further experiments. 
A catheter introduced in the internal jugular vein and exteriorized to the 
back of the pig functioned adequately in most animals. Blood sampling and 
administration of antibiotics and transfusions were easy. However, the 
long-term presence of a central venous line carries with it the hazard of 
air embolism. 
Three animals had bilateral pneumonia after operation, resulting in 
deterioration o~ clinical condition and leading to the death of the pigs 
despite antibiotic treatment. The high incidence o~ in~ection will lead 
to postoperative mortality, especially if immunosuppressive regimens are 
required. 
The value of 
transplantation 
biochemical results in auxiliary partial liver 
in the presence of a host liver that is only deprived of 
portal blood is limited. Rejection could not be predicted by any of the 
used biochemical parameters, but must be con~irmed by histological 
examination of liver biopsies. 
Intravenous angiographical findings in the early phase of the follow-up 
period correlated well with the findings at autopsy. Cholescintigraphy 
proved to be useful in predicting graft function in one pig where uptake 
of the radiopharmacon in the liver and excretion into the duodenum was 
seen. In the other animals no stenosis was shown at the biliodigestive 
anastomosis during cholangiography nor at autopsy. The results of 
cholescintigraphy, therefore, seem to indicate abnormalities at the 
cellular level of the hepatocytes. 
Although immunosuppressive medication was 
occurred more frequently than expected 
not given, chronic rejection 
on the basis of the results of 
orthotopic liver transplantation in pigs where liver transplants may 
survive for considerable periods of time without rejection (3). Acute 
rejection, however, could not be demonstrated, and this is in contrast to 
our observations in dog experiments (18) where auxiliary grafts were 
vigorously rejected in non-tissue-typed donor-recipient combinations 
receiving immunosuppressive medication. The auxiliary liver grafts in the 
present experiments, therefore, seem to be less subject to acute rejection 
than in the dog. I~ the two pigs that died at eight and nine days with 
macroscopically and microscopically healthy liver grafts are taken into 
account, then the number of animals with grafts surviving the period of 
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acute rejection is remarkably high. Incidental histocompatibility between 
donor and recipient caused by a high degree of inbreeding in this strain 
can explain this observation. Tissue typing for the major 
histocompatibility system in pigs has been reported to be of influence on 
liver graft survival (7). Matching, therefore, may probably result in 
better long-term acceptance of liver allografts, reducing the need for 
immunosuppressive therapy and thus decreasing the risks of septic 
complications. 
As a result of the presented experiments it seems justified to further 
explore the possibilities of an auxiliary partial liver graft in 
tissue-typed pigs with induced failure of the recipient liver. 
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Abstract 
A model o£ transient acute hepatic £ailure has been developed in the pig. 
Three days after construction of a functional end-to-side portacaval 
shunt. 15 ambulant animals underwent total liver ischemia for four or six 
hours by the closure of a mechanical occluder surrounding the hepatic 
artery. Four of the eight animals subjected to four hours of ischemia 
survived. All but one of the animals undergoing six hours of hepatic 
ischemia developed grade 4 encephalopathy after 24 to 30 hours and died 
within 50 hours. Quantitative estimation of liver cell necrosis revealed 
less than 40% necrosis in the survivors, and approximately 62% (range 
49-75%) in animals who died of hepatic coma. As far as the putative 
toxins are concerned, significant differences were found between animals 
undergoing four and those undergoing six hours of ischemia. especially in 
the plasma ammonia levels and the plasma ratio's for tyrosine and 
phenylalanine. Plasma arginine levels had fallen to zero in both groups 
at 24 hours and only rose to pre-ischemic values in animals who survived. 
This large animal model fulfills the accepted criteria of potential 
reversibility. reproducibility and death due to hepatic failure. 
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Introduction 
To evaluate new therapies ~or human fulminant hepatic failure a suitable 
animal model is urgently needed. Surgical models such as hepatectomy or a 
portacaval shunt with permanent ligation of the hepatic artery in one or 
two stages, are not ideal because they lack potential 
reversibility1 •2 •3 •4 . To overcome these problems Misra and Fisher created 
a model of reversible hepatic ischemia in ambulant conscious dogs and 
pigs, respectively5 •6 . Sixty minutes of hepatic ischemia were always 
fatal to dogs. For pigs, the minimum period of hepatic ischemia required 
to produce death due to hepatic coma could not be estimated. According to 
other investigators the period of hepatic ischemia tolerated by pigs 
varied between 35 and 180 minutes7 - 10 . Hepatic encephalopathy however 
could not be induced in these studies, since the animals either survived 
or died without a definite period of clinically manifest neurological 
abnormalities. 
The aim of our investigation was to develop a model of acute hepatic 
failure by inducing temporary hepatic ischemia in fully ambulant pigs. and 
to describe the clinical, biochemical, hemodynamic, histological and 
electrophysiological features of this model. 
Methods 
Preparatory surgery. Fifteen healthy Yorkshire pigs, weighing 28-33 kg, 
were used. One and two days before surgery. the bowel was cleansed by the 
oral administration of 25 g of magnesium sulfate and 150 ml of lactulose. 
Anesthesia was induced with an intramuscular injection of ketamine 
chloride (35 mg/kg). The animal was intubated and connected to a 
ventilator; anesthesia 
oxyde-oxygen and enflurane. 
was maintained with a mixture of nitrous 
The anesthetized pig was placed on the 
operating table in a supine position. A Scribner shunt was inserted 
between the carotid artery and the external jugular vein for pressure 
monitoring and blood sampling. The internal jugular vein was cannulated 
with a polyethylene cannula for infusion of fluids. After opening the 
abdomen with a long midline incision the liver was freed by dissecting the 
triangular ligaments, the 
attachments of the liver. 
falciform ligament all peritoneal 
All structures in the hepatoduodenal ligament 
except the portal vein, the hepatic artery and the common duct were 
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devided. Blood vessels running along the vena cava into the liver at the 
level of the diaphragm were interrupted by diathermia. 
A side-to-side portacaval shunt was made, followed by ligation and 
transection of the portal vein close to the hilum to create a functional 
end-to-side shunt. A specially constructed vessel occluder (fig.1) and a 
perivascular electromagnetic blood flow sensor (Skalar Instruments, Inc., 
Delft, the Netherlands) were positioned around the isolated hepatic 
artery; they were anchored to the abdominal wall and the leads were 
guided through the skin via separate incisions. The occluder and flow 
probe were tested during surgery by tightening the occluder, which 
resulted in a total flattening of the blood flo~ curve on the oscillosope 
(fig.2). 
The common bile duct ~as opened and a silicone tube was inserted. This 
tube was ~irmly attached by two 2-0 silk ligatures around the proximal and 
distal ends, thus preventing blood ~low through the wall of the common 
bile duct to the liver. 
Subsequently ~ive silver electrodes {diameter:1 mm) ~ere positioned upon 
the dura, anchored in the skull with acrylic bone cement, and channeled 
percutaneously; two electrodes ~ere placed above the ~rental cortex, one 
in the vertex and two above the occipital cortex. With this technique 
arte~act-~ree registration o~ the electroencephalograms was possible. 
A~ter discontinuation of anesthesia the animals were kept on the operating 
table until they were awake, breathing adequately and restoring their body 
temperature. 
Throughout the surgical procedure 0.9% NaCl ~as administered; just be~ore 
construction of the portacaval anastomosis an additional dose of 400 ml of 
HaemaccelR was given intravenously. At the beginning o~ surgery and 
immediately after~ards ampicillin {0.5 gr) and kanamycin (0.5 gr) ~ere 
injected intravenously. 
Induction of ischemic necrosis. Three days after construction o~ the 
portacaval shunt the normothermic animals, fully awake, were fixed on a 
table ~ith two cotton sheets. The animals accepted this procedure. 
Ischemic hepatic necrosis was induced by thightening the occluder around 
the hepatic artery; 
flattening of the 
arrest of hepatic blood flow ~as confirmed by total 
flow curve on the oscilloscope (fig.2). Arterial 
occlusion ~as maintained for four and six hours, respectively. To 
validate the total devascularization o~ the liver, two animals underwent 
aortography and selective angiography of the hepatic artery. After 
unlocking the occluder, restoration o~ blood flow through the hepatic 
artery was confirmed by continuous registration of the electromagnetic 
~low measurements. 
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open occluded 
Fig. 1 . View of the vessel occluder used to occlude the hepatic artery 
of fully alert pigs. 
Arterial hepatic 
blood flow 
BP 
180 
140 
100 
60 
20 
clamped un-damped 
Fig. 2. Blood flow curve of the hepatic artery and systemic blood 
pressure before, during and after occlusion of the hepatic 
artery. 
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All animals received 35 ml of 8.4% sodium bicarbonate within 15 minutes of 
declamping, followed by a continuous infusion of glucose (12 g/kg/24 hr). 
Penicillin G (9 mega U/24 hr), kanamycin (3 g/24 hr), potassium and 
phosphate (37 mmol/24 hr and 45 mmol/24 hr, respectively) were added to 
the glucose. After the ischemic period, the animals were placed in 
special cages in which they could move around without disturbing their 
continuous infusion. Heart rate and mean arterial blood pressure, 
recorded with an electromanometric transducer, were registered 
continously. Temperature was measured with a tele-thermometer. 
Neurologic assessment. The behaviour of the animals after temporary 
ischemia of the liver was checked frequently. Standard auditory and pain 
stimuli were administered regularly and the responses were graded as 
follows: O=absent; 1=dubious; 2=present. Spontaneous grunting and 
muscular rigidity were also noted. The duration of survival was defined 
as the period between the induction of hepatic ischemia and the time of 
death. 
Electroencephalograms were made before induction of hepatic necrosis and 
repeated at 24, 30, 48, 54 and 72 hrs. Four bipolar tracings (left and 
right fronto-occipital, fronto-frontal and occipito-occipital leads) were 
recorded on a Gogh apparatus (Ahrend van Gogh, Amsterdam, the 
Netherlands). The EEG recordings were analyzed independently by an 
electroneurologist; the 5-grade classification described by Opolon was 
used11 . 
Biochemical measurements. Blood samples were taken before and 24, 30. 48, 
54 and 72 hrs after induction of ischemic hepatic necrosis. In addition 
blood for acid-base status and coagulation studies was also drawn 0.5 hr 
and 1-3 hrs after release of the vessel occluder. Blood glucose, sodium, 
potassium, urea, pH, p02 and pC02, SGOT, bilirubin, bile acids, platelets 
and clotting factors (fibrinogen, activated partial 
thromboplastin time) were measured by standard laboratory techniques. 
Blood samples were cultured in 60 ml of trypticase soy broth at 37° and 
observed for 2-3 days. 
Ammonia was measured by an enzymatic method 12 . Plasma amino acid profiles 
were determined with a LKB-4400 amino acid analyzer (LKB Biochrom. Ltd, 
Cambridge, England) in plasma supernatant which had been rendered protein 
free by treatment with sulfosalicylic acid 75% wjv. The results for the 
neutral amino acids threonine, valine, leucine, isoleucine, tyrosine, 
phenylalanine, tryptophan, methionine and histidine are not expressed as 
simple concentrations but as plasma ratio's. The individual amino-acid 
ratio (for instance threonine) can be calculated as follows: THR/VAL + 
LEU + ILE + TYR + PHE + TRY + MET + HIS + THR. These neutral amino acids 
are transported by the same transport system in the blood-brain barrier 13 . 
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Fig. 3a. A transverse cut of the liver (real size) with 25 points chosen 
at random for analysis of hepatic necrosis. 
Fig. 3b. A magnification (objective 10x) of one area-point which again 
is devided into 25 points for analysis. 
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The ratio o~ the individual amino acids will reflect the influx of 
amino-acids into the brain. 
Morphology. Postmortem examinations were performed in all cases as soon 
as the animal died. After macroscopic inspection of the heart, lungs, 
kidney, stomach and portacaval anastomosis, the liver was removed. Two 
one centimeter thick transverse slices from the upper and lower part of 
the liver were fixed in 10% formaldehyde. After fixation, 7~ sections of 
each complete transversal liver slide were stained with hematoxylin-eosin, 
PAS or gallocyanine. The degree of hepatic necrosis in each slide was 
estimated by point analysis (fig.3a.b); for this purpose 625 areas chosen 
at random were assessed for liver cell necrosis (defined as apparent 
disappearance of hepatocytes or eosinophilic condensation in the cytoplasm 
with nuclear pyknosis). 
Statistical analysis. Data are expressed as mean values ± SD. For 
unpaired samples with a normal distribution of data points, the Student's 
t-test was used, while the Wilcoxon rank sum test was used in the event of 
a skewed data profile. Differences were assumed to be statistically 
significant when the p-values were less than 0.05. 
Results 
Adequacy of the ischemic procedure. For all animals, there was a total 
flattening of the blood flow curve on the oscilloscope during the ischemic 
period. Aortography and selective angiography of the liver of two animals 
showed complete devascularization of the liver. After release of the 
clamp, flow through the hepatic artery was restored in all animals as 
demonstrated by flow measurements (fig. 2). 
Survival. After four hours of ischemia, four out of eight pigs survived 
(fig.4). Two animals died soon after hepatic ischemia due to technical 
complications (broken intravenous tubing and bile leakage from the tube); 
two other animals. that died 26 and 51 hours after ischemia, were found to 
have a positive blood culture with E.coli. After six hours of ischemia, 
six of the seven animals died within 50 hours; one animal survived for 72 
hours with a grade 4 encephalopathy. In four of the six animals death was 
due to hepatic coma; in the two remaining animals death was precipitated 
by a bleeding gastric ulcer. 
Neurological assessment. The surviving animals undergoing four hours of 
ischemia did not show marked abnormalities in behaviour. Immediately 
after revascularization of the liver most pigs were ambulant and alert, 
although some appeared excited. The first abnormality observed in animals 
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that ultimately died was usually an ataxic gait and impaired balance. The 
animals swayed from one side to the other; this was followed by 
drowsiness lasting several hours. Within 28 hours, pain sensations and 
spontaneous grunting had decreased markedly. After loss of sensation coma 
developed between 24 and 30 hours after hepatic ischemia and was 
accompanied by muscular twitching of the neck and limbs, and later 
rigidity. Some hours before death, tachycardia and hyperventilation were 
noted. Terminally, there was gasping with cyanosis, vomiting and 
hypotension. 
The courses of EEG grades for animals undergoing four and six hours 
periods of hepatic ischemia are shown in figure 5. The EEG grades became 
more abnormal in both groups after 24 hours. In general, the EEG changes 
deteriorated very slowly in ·~our-hour pigs'; only one animal had reached 
grade 4 encephalopathy at 48 hours. 'Six-hour pigs showed a rapid 
deterioration o~ the EEG to grade 4 encephalopathy between 24 and 30 hours 
after the ischemic period. 
General and biochemical measurements. Heart rate and mean systemic blood 
pressure remained fairly constant, 
immediately after revascularization of 
except during 
the liver (mean 
a short 
arterial 
period 
blood 
pressure decreased by 20 mm Hg, and there was a mean increase in the heart 
rate of 18 beats per minute). Hypothermia did not develop during the 
experiments. Metabolic acidosis was observed after revascularization, but 
was 
The 
easily corrected by 
levels of plasma 
administration of sodium bicarbonate (fig. 6). 
glucose, potassium and sodium remained within the 
normal range, also after release of the vessel occluder. Plasma SGOT 
levels reached a maximum at 24 hours; 'four-hour pigs' had significantly 
lower levels (2073 ± 817 IU/1) at 24 hours than 'six-hour animals' (3259 ± 
1600 IU/1). 
Coagulation factors (~ig. 7). A remarkable decrease in platelets was 
observed after revascularization of the liver; the lowest value (66 x 
10911) was recorded three hours after revascularization. Platelet 
concentration increased gradually in 'four-hour pigs· but remained low in 
animals that underwent six 
observed ~or coagulation 
hours of 
factors 
ischemia. The 
(NormotestR, 
thromboplastin time and fibrinogen level). 
same course was 
activated partial 
Putative toxins (fig. 8). Plasma ammonia was only moderately elevated at 
24 hrs (162 ± 86 umol/1) in 'four-hour pigs·, in contrast to the levels 
found in animals undergoing six hours of ischemia: 283 ± 113 umol/1 at 24 
hours. 
The plasma ratio's ~or leucine, isoleucine and valine decreased to a 
minimum level at 24 hrs after the ischemic period, without any difference 
between the four and six-hour groups (leucine from 20 to 12; isoleucine 
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~rom 15 to 8, and valine from 32 to 20). The plasma ratio's ~or 
methionine, tyrosine and phenylalanine increased in both groups. In the 
·~our-hour group', the plasma ratio's for tyrosine and phenylalanine 
normalized to pre-ischemic values after 48 hours, while the values for the 
six-hour group remained significantly higher at 30 and 48 hours. 
Significant differences in the ratio for tryptophan were not found. With 
this relatively insensitive method. GABA levels could not be detected in 
plasma exept in two animals (1 .6 - a.o nmol/1). 
Urea cycle amino acids (fig.9). In both groups serum arginine levels had 
dropped to zero 24 hrs after the ischemic period. The plasma arginine 
levels gradually returned to the initial values in all but one of the 
'four-hour animals', while remaining zero in six of the seven animals that 
underwent six hours of ischemia. The plasma ornithine and citrulline 
levels increased in both groups but the rise was only significant in 
'six-hour animals·. 
Histology (table I). In 'four-hour p~gs a mean of 42% of liver cells 
showed total necrosis. In those who died, more than 50% of the liver 
cells were necrotic. and in those two survived less than 40%. Six hours 
of ischemia resulted in a mean necrosis of 62% (range 49-75%). Necrosis 
of 50% or more resulted ultimately in hepatic coma in nine out of thirteen 
animals. It should be mentioned that beyond the necrotic areas large 
fields of degenerated hepatocytes were always seen; these cells were not 
included in the quantative assessment of liver cell necrosis. 
Table 1. Quantitative assessment of liver necrosis by point analysis 
of whole liver slices. 
4 hrs of liver ischemia 6 hrs of liver ischemia 
survival(hrs) %necrosis survival(hrs) %necrosis 
pig no 1 72 15 20 70 
2 26 68 20 66 
3 10 67 29 49 
4 72 34 72 50 
5 72 36 50 50 
6 72 34 43 75 
7 6 * 30 69 
8 51 * 
* . no histology available 
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Discussion 
Our experiments show that ischemia of the liver in fully ambulant 
normothermic pigs was often tolerated for four hours, but that six hours 
of hepatic ischemia was usually followed by hepatic coma and death. 
Previous studies had failed to identify the minimum ischemic period 
required to produce hepatic coma in non-anesthetized pigs mainly because 
of poor reproducibility6 Our results, however, confirm several recent 
reports that the normothermic liver appears to be more resistant to 
ischemia than previously appreciated9 • 10 . 
Except for the duration of transient hepatic ischemia other factors may 
influence the effect of hepatic ischemia on survival. Anesthesia with its 
variations in duration and depth and the variable metabolic disturbances 
associated Yith surgery may modulate the extent of liver damage and 
thereby the final outcome5 . Therefore, in contrast to most previous 
studies7 • 10 • we induced transient hepatic ischemia in the pig after the 
effects of anesthesia and surgery had disappeared. 
The time interval betveen initial surgery and the induction of liver 
ischemia is said to influence the extent of liver cell necrosis due to the 
formation of collaterals6 • 14 . Since we had nearly always observed 
encephalopathy and death due to massive necrosis of the liver in earlier 
experiments with non-surgical induction of permanent hepatic ischemia15 , 
we have continued to use a time interval of three days between initial 
surgery and the non-surgical induction of hepatic ischemia. A potential 
source of collateral circulation in a model based on transient ischemia is 
the wall of the common bile duct. This structure contains a netvork of 
blood vessels which can supply an appreciable amount of blood to the 
liver. Therefore a short piece of tubing was placed in the common bile 
duct and the blood flow along the common duct was interrupted by two 
ligatures around the tube ends. 
Another factor that could affect liver cell necrosis and thus the duration 
of tolerable liver ischemia is the amount of putative toxins that appear 
in the anhepatic state. Extensive bevel cleansing before induction of 
hepatic ischemia and an adequate supply of calories afterwards vere 
included in our protocol in an attempt to minimize the disturbances of the 
'milieu interieur'. 
Is this an adequate model of acute hepatic failure? The requirements for 
a satisfactory animal model of acute hepatic failure, as compiled by 
Terblanche include: (1) potential reversibility; (2) reproducibility; 
(3) death due to hepatic coma after elapse of a time period sufficiently 
long to allow hepatic support procedures to be instituted; (4) the use of 
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a large animal; (5) induction of liver necrosis without biohazard4 • 
Reversibility. Since hepatic circulation is restored in our model 
(albeit only through the hepatic artery). the potential for recovery and 
regeneration is present. Histologically six hours of hepatic ischemia 
resulted in necrosis less than 75% of the liver cells. None of the 
animals had a totally (90-100%) necrotic liver. Therefore, at least 25% 
of the liver tissue remained available for recovery and possibly 
regeneration, assuming that the majority of cells in various stages of 
degeneration retain the potential of recovery in a normal "milieu 
interieur" 17 • 18 • 
Reproducibility. All animals subjected to six hours of ischemia 
developed severe encephalopathy (EEG grade 4) within 30 hours and died 
within 20 to 50 hours, except ~or one animal that survived ~or 72 hours. 
The histological data showed necrosis o~ 50-75% o~ the liver and all 
biochemical measurements, including analysis o~ putative toxins were 
~airly uni~orm. The variations in observations which are inherent to any 
biological experiment appear less prominent in our model than in most 
models ~or drug-induced acute hepatic ~ailurei 9 • 20 . 
Death from liver failure. Within 30 hours all animals that underwent 
six hours o~ hepatic ischemia developed sev~re encephalopathy which was 
~allowed by death. In two animals liver failure was complicated by 
gastric hemorrhage that resulted in early death. With respect to this 
complication, stress induced by insufficient freedom of movement might be 
o~ pathogenetic importance in this animal species. Endotoxemia and 
bacteremia were excluded as non-hepatic causes o~ death in our earlier 
studies16 . The time between induction o~ ischemia and the development of 
encephalopathy and death is about 24 and 48 hours respeetively: sueh a 
period is sufficiently long for introduction of an experimental treatment 
and evaluation of its ef~ects. 
Other requirements for an appropriate animal model are the use o~ a 
large animal and minimal hazards to personnel. In our model highly inbred 
pigs were used. The model o~ hepatic ischemic necrosis does not require 
the use of dangerous toxic substances. 
We think there~ore that our animal model fulfills all the criteria 
proposed for an appropriate animal model of fulminant hepatic failure4 . 
Several other interesting observations with regard to this animal model 
were made. 
1. Clinical neurological assessment by means of semi-quantitative 
measurements was of restricted diagnostic value and distinguished only 
non-coma from coma. In contrast EEG assessment identified all grades of 
encephalopathy in pigs with ischemic hepatic necrosis. Automated EEG 
analysis showed that objective measurement of encephalopathy in pigs is 
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~easible. 
2. Hepatic ischemia for six hours did not, in itself, induce marked 
abnormalities in coagulation tests. However, as soon as revascularization 
of the ischemic liver was established severe disturbances developed. A 
marked drop in platelet count and in the levels of fibrinogen and other 
clotting factors was observed, suggesting intravascular coagulation. 
Exposure of the blood to damaged sinusoidal cells within the ischemic 
liver seems a likely explanation for the observed findings21 No 
reduction in platelet counts was observed in earlier experiments in pigs 
with permanent ischemia of the liver that showed a decrease in the levels 
of clotting factors to 20~ at 24 hours15 •22 •3 1 • 
3. Tyrosine and phenylalanine ratio's clearly increased in our model. 
Elevation o~ the tyrosine ratio was greater ~or the 'six hour animals' and 
there~ore seems to be related to the degree o~ hepatic insuf~iciency23-27 . 
Correlations between the degree of liver cell necrosis and other amino 
acids ratio's were not ~ound. Assuming that disturbances in the transport 
of amino acids across the blood-brain barrier are best expressed by plasma 
ratio's, tyrosine appears to be the major abnormality of neutral amino 
acids in hepatic encephalopathy in the pig. These observations contrast 
with the ~indings in rats and dogs of a concurrent rise of tyrosine, 
phenylalanine and tryptophan. 
4. Associated with the liver failure was a decrease in plasma arginine 
levels o~ more than 90%. In animals who survived, the plasma arginine 
levels normalized, but they remained zero in those who died. Arginine is 
required for effective utilization of ammonia in the urea cycle28 . A 
correlation between the persistent absence of plasma arginine and the 
rapid rise in ammonia may be entertained. However, the observation that 
arginase is released from the necrotic liver cells into the plasma 
compartment29 •3°, and the observation that it induces conversion of plasma 
arginine into ornithine and urea (a rise in plasma ornithine levels was 
indeed observed, fig. 10), emphasizes the need for measurements of 
intracellular concentration of arginine before inferences about the 
activity of the urea cycle can be made. 
In conclusion we believe that our animal model of acute hepatic failure is 
comparable to the human condition of acute hepatic failure. Since the 
model is reversible as well as reproducible and does not constitute a 
biological hazard, it can be used for studies of the pathogenesis and 
complications of acute liver failure. Moreover, since our model utilizes 
a large animal with a life expectancy of about 48 hours, testing of 
hepatic support systems or assessment of auxiliary liver transplantation 
is possible. 
73 
Literature 
1. Giges B, Demn HL, Sborov VM, et al. Experimental hepatic coma. 
2. 
3. 
Surg Gynecol Obstet 1953; 97: 763-768. 
Tonnesen K. Total devascularization of 
experimental model of acute liver failure. 
1976; 11 (suppl 37): 23-26. 
the liver. An 
Scand J Gastroent 
Rappaport 
following 
748-762. 
AM, Malcolm PH D, MacDonald H, et al. Hepatic 
ischemia of the liver. Surg Gynecol Obstet 1953; 
coma 
97: 
4. Terblanche J, Hickman R, Miller D, et al. Animal experience with 
support systems: are there appropriate animal models of 
fulminant hepatic necrosis? In: Artificial Liver Support. 
Edited by Williams R, Murray-Lyon I. London, Pitman, 1975; p 
163-172. 
5. Misra MK, Peng FK, Sayhoun A, et 
canine model. Surgery 1972; 72: 
al. Acute 
634-642. 
hepatic coma: a 
6. Fischer M. StOtter L, Schmahl W, et al. 
due to temporary hepatic ischemia 
Hepato-Gastroenterol 1976; 23: 241-249. 
Acute liver failure 
in the pig. Acta 
7. Battersby 
the pig: 
Br J surg 
c, Hickman 
1. The 
1974; 61: 
R, Saunders SJ, et al. Liver function in 
effects of 30 minutes normothermic ischemia. 
27-32. 
8. Fredlund PE, Ockerman PA, Vang JD. Acidosis and increased plasma 
levels of B-D glucosidase and B-P galactosidase after hepatic 
inflow occlusion in the pig. Acta Chir Scand 1974; 140: 234. 
9. Nordlinger B, Douvin D, Javaudin L, et al. An experimental study 
of survival after two hours of normothermic hepatic ischemia. 
Surg Gynecol Obstet 1980; 150: 859-864. 
10. Harris KA, Wallace AC, Wall WJ. Tolerance of the liver to 
ischemia in the pig. J Surg Res 1982; 33: 524-530. 
11. Opolon P, Lavalland MC, Huguet CL, et al. 
cross-dialysis in experimental hepatic coma. 
1 976; 1 42: 845-854. 
Hemodialysis versus 
Surg Gynecol Obstet 
12. da Fonseca, Wollheim. Direkte plasma-ammoniak 
enteiweissung. z Klin Chern Biochem 1973; 11: 
bestimmung 
426-431 . 
ohne 
13. Partridge WM, Oldendorf WH. Transport of metabolic substrates 
through the blood-brain barrier. J Neurochem 1977; 28: 5-12. 
74 
14. Joyeuse RB, Ivanisevic WP, 
experimental hepatic coma 
Gynecol Obstet 1963; 117: 
Longmire Jr 
'oy parabiotic 
129-134. 
JV. The treatment of 
cross circulation. Surg 
15. de Groot GH, Schalm 
large-pore membrane 
hepatic insufficiency 
65-71. 
SW, Schicht 
hemodialysis 
in pigs. Eur 
I • 
and 
J 
et al. Comparison of 
cross dialysis in acute 
Clin Invest 1983; 13: 
16. de Groot GH, Schalm SW, Batavier P, et al. Endotoxemia in 
with ischemic hepatic necrosis treated by lactulose 
pigs 
and 
30, hemodialytic procedures. Hepatogastroenterol 1983; 
240-242. 
17. James J, Myagkaya GL. De celdood; nieuwe inzichten in een cud 
probleem. Ned T Gen 1983; 35: 1572-1578. 
18. Frederiks WM, James J, Bosch KS, et al. A model for provoking 
ischemic necrosis in rat liver parenchyma and its quantitative 
analysis. Exp Pathol 1982; 22: 245-252. 
19. van Leenhoff JW, Hickman R, Saunders SJ. Massive liver cell 
necrosis induced in the pig with carbon tetrachloride. S Afr Med 
J 1974; 48: 1201-1204. 
20. Miller DJ, Hickman R, Fratter R. An animal model of fulminant 
hepatic failure: a feasibility study. Gastroenterol 1976; 71: 
109-113. 
21. Dinbar A, Rangel DM. Fonkalsrud EW. Effects of hepatic 
Application 
269-276. 
ischemia 
to liver on coagulation in primates. 
transplantation. Surgery 1970; 68: 
22. Tonnesen K. Experimental liver failure. Acta Chir Scand 1977; 
143: 271-277. 
23- Mazzetti A, Bernardi M, Antonini L, et al. Plasma amino acid 
24. 
patterns in experimental acute hepatic failure: comparison 
between hepatectomy and liver devascularization in pigs. Surgery 
1981; 90: 527-534. 
Wustrow Th, van Hoorn-Hickman R. van Hoorn WA, et al. Acute 
hepatic ischemia in the pig; the changes in plasma hormones, 
amino acids and brain biochemistry. Hepato-Gastroenterol 1981; 
28, 143-146. 
25. Chase RA, Davies M, Trewby PN, et al. Plasma amino acid profiles 
in patients with fulminant hepatic failure treated by repeated 
polyacrilonitrile membrane hemodialysis. Gastroenterol 1978; 
75: 1033-1040. 
26. Munro HN, Fernstrom JO, Wurtman RJ. Insulin 
imbalance and hepatic coma. Lancet 1975; 1: 
plasma amino 
722-724. 
acid 
27. Rosen HM, Yoshimura N, Aguivre A, et al. 
patients with acute hepatic failure. 
483-487. 
75 
Plasma amino acids in 
Gastroenterol 1977; 72: 
28. Zieve L. Amino acids in liver failure. Gastroenterol 1979; 76: 
219-221. 
29. Cacciatore L, Antoniello S, Valentino B, et al. Arginase 
activity, arginine and ornithine of plasma in experimental liver 
damage. Enzyme 1974; 17: 269-275. 
30. Vijaya S, Nagarajan B. Arginine metabolism in rat liver after 
hepatic damage. Biochem Med 1982; 27: 86-94. 
31. de Groot GH, Schalm SW, Schicht I, et al. Large-pore 
haemodialytic procedures in pigs with ischaemic hepatic necrosis; 
a randomized study. Hepato-Gastroenterol 1984; 31: 254-260. 

CHAPTER 5 
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Abstract 
In pigs subtotal ischemic liver cell necrosis was induced ~our days after 
auxiliary transplantation of 60% of the liver of a MLC-compatible donor 
(ATPL group, n=13). In control animals (n=14) temporary liver ischemia 
was preceded by division of the hepatic ligaments and creation of an 
end-to-side portacaval shunt. 
In the ATPL group six animals died from gastric hemorrhage, intestinal 
strangulation, or sepsis. The remaining seven animals survived in 
excellent condition until sacrifice 26 days after the induction of liver 
ischemia. 
Excellent graft function was demonstrated by uptake and excretion of 
ggmTc-HIDA at cholescintigraphy, ammonia detoxification, synthesis of 
clotting factors and glucohomeostasis. Electroencephalographic recordings 
in the animals that underwent transplantation, did not change from 
preischemic levels. Evidence of hepatic regeneration was found in the 
transplanted livers but could not be demonstrated in the damaged host 
livers. The control animals died in coma within 72 hours. 
These results indicate that auxiliary transplantation of a partial liver 
provides metabolic support and improves survival in animals with induced 
acute liver failure. 
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Introduction 
The mortality rate in patients with acute hepatic ~ailure is 80-90%1 . 
Death is usually caused by cerebral edema, brain stem dysfunction with 
respiratory or circulatory failure, or bleeding, resulting from the 
inadequacy of hepatic metabolism and protein 
often mentioned. but rarely documented2 . A 
synthesis. 
variety of 
Regeneration is 
modalities of 
artificial liver support systems have been used in an attempt to prolong 
the life of these patients until the diseased liver has recovered from the 
insult, but none of these has been proved to be effective3 . If the 
concept is valid that the liver will regenerate if time permits, better 
support systems should be developed. 
Transplantation of a liver allograft in the heterotopic auxiliary position 
is a potential candidate for such a hepatic support system since it leaves 
the host liver in-situ and surgically it is a less extensive procedure 
than orthotopic liver transplantation. 
recovered, the graft can be removed. 
If the patient's own liver has 
However, results of clinical and experimental studies in auxiliary liver 
transplantation have been disappointing, with a few exceptions4 - 8 • 
To prove that a heterotopic liver transplant can support life during acute 
hepatic failure a reproducible animal model of acute hepatic failure was 
developed (Chapter 4). In this article we report the beneficial effect of 
auxiliary transplantation of 60% of the liver on animal survival and 
hepatic function in pigs with induced acute hepatic failure. 
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Methods. 
Thirty-seven female Yorkshire pigs, weighing kg 
(mean±SEM), were used. Donor and recipient were of similar size and body 
weight. The animals were randomly allocated to two groups: animals in 
group A (n=17) underwent an auxiliary partial liver transplantation while 
control animals (group B, n=20) received an end-to-side portacaval shunt. 
Four days after the first operation the native liver of the animals in 
both groups was rendered ischemic by occlusion of the hepatic artery for 
six hours. 
Surgical technique. 
Group A. Heterotopic liver transplantation was performed as described 
previously9 . After removal of the donor liver organ, perfusion was 
started ex-vivo through a cannula in the portal vein using Euro-Collins 
solution (4° C). A cholecystectomy was performed and a polyethylene tube 
was inserted through the cystic duct into the common bile duct for 
cholangiography studies. The two le£t lateral lobes o£ the donor liver 
were resected. reducing the liver graft weight to 62.9±1 .1% (mean±SEM). A 
continuous atraumatic 2/0 polydiaxonone (EthiconR) suture was placed at 
the cut sur£ace after resection. 
In the recipient animal all the liver ligaments were transected. A 
silicone tube was inserted into the common bile duct and two 2/0 silk 
ligatures were tied around this tube to prevent collateral circulation 
through 
vessel 
the wall o£ 
occluder and 
the 
an 
duct to the host liver. A specially 
electromagnetic blood £low sensor 
designed 
(Skalar 
Instruments. Inc., Del£t, the Netherlands) were placed around the isolated 
hepatic artery of the recipient and the leads were guided through the 
abdominal wall • 
The transplant was placed in the right subhepatic space. 
Revascularization o£ the gra£t was obtained by end-to-side anastomosis 
between the suprahepatic vena cava of the graft and the infrahepatic vena 
cava o£ the recipient. Inflow a£ portal blood was achieved by end-to-side 
anastomosis between the donor portal vein to the recipient portal vein 
£allowed by an end-to-side anastomosis of the graft hepatic artery to the 
recipient's infrarenal aorta. The host portal vein was ligated and 
divided in the liver hilum. Restoration o£ the bile £low was achieved by 
an end-to-side choledochoduodenostomy (Fig.1 ). Four silver electrodes 
were placed on the dura through burr holes for electroencephalographic 
monitoring. 
Host 
Liver 
~od. 
Occluder 
Sensor 
Fig. 1. Schematic drawing of the auxiliary partial livertransplantation 
VC = vena cava, Hep.Art. ~ hepatic artery, PV = portal vein. 
Duod. = duodenum, CBD = common bile duct. 
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Group B. In the control animals all the liver ligaments were transected 
and an end-to-side portacaval shunt was constructed. A silicone tube was 
inserted into the common bile duct; a flow sensor and vessel occluder 
were placed around the hepatic artery and cerebral electrodes were 
positioned as well. 
Throughout the surgical procedures Ringer's solution was administered. In 
group A all animals received a blood transfusion of 400 ml obtained from 
the donor animal to correct blood loss during the transplantation 
procedure. Just before recirculation of the transplant or 
the portacaval anastomosis an additional 500 ml of 
construction of 
HaemaccelR was 
administered. All animals received ampicillin (0.5 g) and kanamycin 
(0.5 g) intravenously at the beginning of surgery and 
afterwards. 
Immunosuppression. No immunosuppressive drugs were given. 
immediately 
Donor and 
recipient combinations were matched for the mixed lymphocyte reaction test 
as described previously10 . 
Induction of acute hepatic failure. Four days after the operation 
ischemic hepatic necrosis was induced in both groups by tightening the 
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externally driven occluder around the hepatic artery without anesthesia. 
Total arrest o£ 
flow monitoring. 
the hepatic 
The arterial 
blood flow was confirmed by electromagnetic 
occlusion lasted for six hours. Just 
before induction of liver ischemia and immediately afterwards 0.5 g 
ampicillin and 0.5 g kanamycin were administered intravenously. During 
hepatic artery occlusion all animals received a continuous infusion of 
glucose (12g/kg/24 hr) to which 
phosphate (37 mmol/24 hr and 
cimetidine (800 mg/24 hr), potassium and 
45 mmol/24 hr respectively) were added. 
Sodium bicarbonate {30 ml, 8.4%) was given directly after restoration of 
hepatic artery blood flow to correct metabolic acidosis. 
Follow-up studies. Blood samples were taken before surgery, the first 
postoperative day, before induction of ischemic hepatic necrosis, 24 and 
48 hours after liver ischemia and weekly thereafter. Hemoglobin, WBC, 
platelets, serum levels of glucose, bilirubin, SGOT, venous ammonia and 
fibrinogen, the NormotestR and the activated partial thromboplastin time 
(APTT) were determined by standard laboratory techniques. 
Electroencephalograms (EEGs) were made before induction of hepatic 
necrosis and repeated at 24, 48. and 72 hours and just before sacrifice at 
26 days. The EEG recordings were read independently by an 
electroneurologist and graded 0-5 as described by Opolon11 Intravenous 
angiography, as described previously12 , was performed one and three weeks 
after host liver ischemia. During this procedure a cholangiography of the 
liver transplant was also done. 
Cholescintigraphy of the transplant with 99mTc-HIDA as described in detail 
elsewere9 , was carried out weekly after induction of ischemia. 
DNA and RNA contents of the transplant and the recipient liver at surgery 
and at sacrifice were calculated by multiplying the amount of nucleic 
acids per gram wet 
of the liver13 . 
weight of liver biopsy specimens with the total weight 
The wet weight of the recipient liver at the time of 
surgery was estimated by taking the weight of the liver of pigs of the 
same sex, age and body weight. 
Histology. Wedge liver biopsies were taken at operation and at autopsy. 
Percutaneous needle biopsies of the transplant and the host liver were 
carried out in the first week after acute host liver failure. Specimens 
were stained with hematoxylin, azophloxin and saffron and then examined on 
a blind observer basis. An assessment was made of the presence and degree 
of cholangitis, cholestasis, 
infiltration. Rejection was 
hepatocellular necrosis, 
estimated by the degree 
and cellular 
of periportal 
cellular infiltration and vasculitis. Postmortem examinations were 
performed in all cases. 
Surviving animals were sacrificed 26 days after inducing host liver 
ischemia. 
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Statistical analysis. Data are expressed as mean values :!: SEM. 
Statistical analysis was performed using the Wilcoxon rank-sum test. 
Results. 
Survival. No deaths occurred intraoperatively. In group A (n=17) four 
animals died before the induction of host liver ischemia. Two pigs died 
because of technical failure (portal vein thrombosis; air embolism) and 
two pigs died of pneumonia and bleeding from a gastric ulcer. The 
remaining thirteen animals provide the data for further evaluation of 
group A. 
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Fig. 2. Animal survival after the induction of ischemia. Solid line 
represents animals that received an auxiliary partial liver 
transplant. Interrupted line represents control animals. 
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In the control group (n~20) six animals were excluded from the study. 
Four pigs died before induction of hepatic failure (kinking of the hepatic 
artery by the vessel occluder resulting in hepatic failure before the 
fourth postoperative day, transfusion of incompatible blood and bleeding 
from the central venous line). Two animals had to be excluded because the 
occluder around the hepatic artery did not function. 
Median animal survival in group A after six hours of acute host liver 
ischemia and auxiliary partial liver transplantation was 26 days (fig.2). 
Seven animals were sacrificed at the end of the experiment in excellent 
condition 26 days after the ischemic period. Death in the other animals 
was due to upper gastrointestinal bleeding (four cases), sepsis and 
intestinal strangulation. All animals in this group had vital grafts at 
autopsy examination. In the control group (B) median animal survival was 
29.5 hours (p< 0.001 compared with group A). After liver ischemia twelve 
animals died spontaneously within 72 hours and two pigs had to be 
sacrificed after this period with a grade 4 encephalopathy. In all cases 
death was due to acute hepatic failure. although in two pigs death was 
precipitated by a bleeding gastric ulcer and one pig had concomitant 
intestinal strangulation. 
Ischemic procedure. The procedure of inducing acute hepatic failure by 
host liver ischemia was initially well tolerated by all animals in both 
groups. Flattening of the blood flow curve on the oscilloscope indicated 
total hepatic artery occlusion in all pigs. The flow through the hepatic 
artery was restored immediately in all but two animals after release of 
the vessel occluder as demonstrated by flow measurements. Thrombosis of 
the hepatic artery at the site of the vessel occluder was seen in four 
animals at autopsy examination. In all the other animals in both groups 
the hepatic artery was patent. Histology of the liver in group B showed 
an estimated 85~ necrosis at autopsy; only small zones of 
normal-appearing hepatocytes were seen around the vena cava, close to the 
liver capsule, and near the diaphragm. The same picture was observed in 
the host liver of the animals in group A that died shortly after induction 
of liver ischemia. In the animals with long-term survival in group A the 
host liver was transformed in a flat fibrotic structure adhaerent to the 
diaphragm. It should be mentioned that large fields of normal-appearing 
hepatocytes were always seen in the host liver at autopsy examination 26 
days after liver ischemia. 
Electroencephalography. Electroencephalography readings in group A just 
before induction of ischemia scored o to 2 (fig.3). No significant 
changes were noticed in the first three days after ischemia or just before 
sacrifice. In group B the EEG readings deteriorated in all animals in the 
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days after hepatic ischemia. All pigs that survived 48 hours had reached 
grade 3 or more. 
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Fig. 3. EEG readings in animals that underwent ATPL prior to ischemia 
(group A) and in animals that did not receive an auxiliary 
partial liver transplant (group B). 
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Fig. 4. Fibrinogen levels, APTT, normotestR and platelet counts after 
six hours liver ischemia in animals that underwent ATPL (group A, 
o-----o) and in control animals (group B, •-----e). * p < 0.01, 
compared with controls. 
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Biochemistry. In all the animals that received an auxiliary partial liver 
transplant before induction of host liver failure, transient minor changes 
were observed in fibrinogen level, activated partial thromboplastin time, 
NormotestR and platelet counts, which rapidly returned to normal values 
(fig.4). In group B a decrease in coagulation factors was observed in all 
animals, which was clinically confirmed by oozing of blood from the 
surgical incisions indicating hemorrhagic diathesis. 
In all pigs there was a significant rise in 
values after the ischemic period (fig.5). 
normal within one week. The transplants in 
serum bilirubin and SGOT 
The levels in group A became 
group A showed excellent 
ammonia detoxification as compared with the values in group B. Blood 
glucose levels were within normal range in both groups, but in the control 
animals glucose 20% was administered continuously to prevent death ~rom 
hypoglycemia after liver ischemia whereas the pigs in group A showed 
glucohomeostasis without glucose infusion. 
Groft survival. Excellent graft ~unction in group A was demonstrated by 
synthesis o~ clotting factors, ammonia detoxification, glucohomeostasis, 
and animal survival after host liver ischemia. In addition, sequential 
HIDA-hepatobiliary scintigraphy was performed in seven animals surviving 
more than one week. All grafts showed normal uptake o~ the radiopharmacon 
in the liver and excretion into the duodenum. Scintigraphy showed slight 
uptake in the recipient liver in three cases the recipient liver o~ the 
other four animals could not be visualized. Patency of all hepatic artery 
and portal anastomoses in these seven animals was demonstrated by 
intravenous angiography. Cholangiography showed no bile leakage or 
stenosis at the choledochoduodenostomy. 
At autopsy examination all vascular and bile duct anastomoses were patent 
in all pigs that received an auxiliary partial liver transplant. The 
grafts appeared to be virtually normal at macroscopic inspection. 
Histologic examination showed only mild or moderate signs o~ chronic 
rejection in the animals that survived more than one week. Acute 
rejection as indicated by vasculitis was not seen and hepatocellular 
necrosis was not prominent in the grafts. 
mild to moderate was seen in seven cases. 
Cholangiolitis ranging ~rom 
Determination o~ nucleic acid contents o~ the transplants in the animals 
o~ group A that survived one month suggested compensatory hyperplasia 
(~ig.6). DNA and RNA contents of seven liver grafts at sacrifice 
increased with 31%±16% and 48%±16%, respectively, compared with values at 
the time of transplantation (p=0.06). DNA and RNA contents of recipient 
livers in the same animals decreased signi~icantly with 43%±10% and 
69%±2%, respectively. 
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Fig. 5- Plasma ammonia concentrations, SGOT and bilirubin levels in 
animals that underwent ATPL (group A. o-----o) and in control 
animals (group B, o-----o). * p < 0.01, ** p < 0.001, compared 
with controls. 
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Discussion 
In our experimental model acute host liver failure was induced by ischemia 
of the liver for six hours. In another study we demonstrated that 
ischemia for four hours resulted in a 50% survival rate but that six hours 
of hepatic ischemia was followed by hepatic coma and death in all animals 
(Chapter 4). It is important that all hepatic ligaments are meticulously 
divided and that collateral circulation through the wall of the common 
bile duct is interrupted. Without this additional procedure survival 
after hepatic artery occlusion and portacaval shunting is still possible. 
All requirements for a satisfactory animal model of acute hepatic failure 
as stated by Terblanche et al. are met in this experimental model 14 
(i.e. • 
after 
potential 
a period 
reversibility, reproducibility, 
of time sufficiently long to 
support procedures, the use of a large animal, 
death caused 
allow studies 
and induction 
by coma 
on hepatic 
of liver 
failure with minimal hazards to personnel). Death from liver failure 
occurred in all animals in group B after induction of acute liver failure. 
The severity of liver insufficiency was reflected by the degree of 
encephalopathy, clotting disorders, and increase in liver enzymes. The 
auxiliary transplants consisting of 60% of a donor liver were able to 
sustain life in the pigs in group A. Excellent metabolic support by the 
graft was demonstrated by synthesis of clotting factors and ammonia 
detoxification. 
The EEG readings before induction of ischemia were abnormal in some 
animals in both groups. Portacaval shunting might explain the abnormal 
EEG readings in group B, while in group A suboptimal graft function might 
be responsible. It has been demonstrated by others that portacaval shunts 
in pigs result in increased levels of ammonia15 . The EEG readings in 
group A remained slightly abnormal but in group B severe encephalopathy 
was reached within 48 hours. 
Hyperplasia in the transplanted livers in the pigs with long-term survival 
was demonstrated by the increase in both DNA and RNA content. However, in 
all recipient livers, few signs of regeneration were seen after the 
ischemic period, although areas with normal-appearing hepatocytes were 
always present. Data on liver regeneration after partial hepatectomy have 
been reported extensively16 , but reports on regeneration after toxic, 
viral or ischemic liver damage are less numerous2 •17 •18 . 
Results of previous experiments in which the ability of an auxiliary 
hepatic graft to prolong life and to induce regeneration in the recipient 
liver in the presence of acute host liver failure have been controversial. 
Auxiliary liver transplantation in dogs with chemically induced liver cell 
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necrosis resulted in an 80% animal survival rate, while all control 
animals died within six days after administration of a hepatotoxic agent4 . 
However, death in the control animals occurred without evidence of severe 
hepatic failure. Heterotopic liver transplantation was carried out by 
Lilly et al. in pigs 24 hours after hepatic ischemia induced by hepatic 
artery ligation and mesenteric-caval shunt5 . A good rate of survival was 
obtained in the pigs that underwent transplantation, while all control 
animals died within 72 hours. However, after removal of the liver grafts 
within ten days all grafts appeared to be totally infarcted with necrosis 
and abscess formation. Nevertheless it was stated that total host liver 
recovery occurred within this short period of time. Others have been 
unable to reproduce this experiment7 . Diaz et all transplanted dogs whose 
hepatic lesions were produced by peroperative clamping of the porta 
hepatis after construction of a portacaval shunt 6 . After removal of the 
graft only one dog survived for 25 days. Using an identical experimental 
model, Szekely et al. found that the first signs of regeneration in the 
host liver appeared only several days after the end of hepatic support19 . 
It should be noted that in none of the described experiments was 
splanchnic blood directed into the graft. It has been shown that efferent 
pancreatic blood is essential for the integrity and optimal function of 
the liver. Without portal blood liver atrophy will most likely 
ensue
20
-
22 In our experiment the liver graft was provided with portal 
blood while the portal vein of the recipient was transected in the liver 
hilum to ensure optimal graft perfusion. Therefore regeneration of the 
host liver in our study may have been impaired by the lack of hepatotropic 
factors. Furthermore the follow-up period may have been too short to 
detect host liver regeneration. 
It still remains questionable whether sufficient regeneration in the liver 
after extensive toxic or ischemic injury does occur. Longer follow-up 
periods and further studies on host liver regeneration with intact portal 
are needed. If induction of liver failure predates the 
transplantation procedure, which will be the case in man, the host portal 
vein may not need to be ligated as an intrahepatic block present in 
patients with acute liver failure, will probably direct sufficient portal 
blood flow through the graft23. 
The problem of space after an auxiliary liver transplantation in the 
abdominal cavity was circumvented in our study by reducing the size of the 
graft to 60% of its original weight. This avoided compression on blood 
vessels impairing graft function and diminished the possibility of 
cardiopulmonary dysfunction by elevation of the diaphragm. Futhermore the 
partial hepatectomized liver transplant mcy release a 
regeneration-stimulating factor that might enhance repair mechanisms in 
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the diseased host liver24 . 
The concept of auxiliary transplantation of the liver in the presence of 
host liver failure is to remove the graft after the transplantation 
procedure once the patient's oYn liver has recovered. However, the gra£t 
can be left in-situ if the host liver fails to regenerate. 
The results of our study indicate that an auxiliary partial liver 
transplant is capable of providing metabolic support during and after 
fulminant hepatic failure even if host liver regeneration does not occur. 
We would therefore recommend that auxiliary heterotopic liver 
transplantation is reconsidered in patients with fulminant acute liver 
failure or in patients with chronic non malignant liver disease in whom 
the procedure of orthotopic liver transplantation carries too much risk. 
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HEMODYNAMICS AND COAGULATION DISORDERS IN EXPERIMENTAL AUXILIARY LIVER 
TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE 
This chapter has been submitted for publication 

HEMODYNAMICS AND COAGULATION IN EXPERIMENTAL 
TRANSPLANTATION DURING FULMINANT HEPATIC FAILURE1 
AUXILIARY LIVER 
Cornelis B. Reuvers2 , M.D., 
Groenland3 , M.D., Anton L. 
Onno T. Terpstra2 , M.D., Thee H.N. 
Boks4 , N. Simon Faithfu113 , M.B., PhD., 
F.F.A.R.C.S .• Fibo W.J. ten Kate5 , M.D. 
Departments of Surgery2 , Anesthesiology3 , Medicine4 and From the 
Pathology5 of the University Hospital, Erasmus University, Rotterdam, The 
Netherlands. 
1This study was supported by a grant from the Sophia Foundation for 
Medical Research. 
100 
Abstract 
In pigs ischemic liver cell necrosis was induced by 6 hours occlusion of 
the hepatic artery and the portal vein 3 days after construction of a 
side-to-side portacaval shunt and division of the hepatic ligaments. 
Two-third of the liver of a MLC-compatible donor was heterotopically 
transplanted 13 hr {group I), and 3 hr (group II) after induction of liver 
failure. 
In group I (n=11) 3 animals died of liver failure before or shortly after 
induction of anesthesia. Of the remaining pigs, 2 animals survived more 
than 2 weeks. In group II (n=10) intraoperative hYPotension was prevented 
by the reduction of the interval between liver failure and 
transplantation, and by fluid replacement that was monitored by a 
thermodilution catheter. Significant decrease in cardiac out~ut and 
increase in pulmonary and systemic vascular resistance were observed 
during auxiliary partial liver transplantation {APLT). In the immediate 
postoperative period 6 pigs died of deficiencies in hemostasis that were 
caused by consumptive coagulopathy related to severe host liver damage 
rather than fibrinolysis. Two pigs in group II survived in good condition 
12 and 42 days a£ter APLT. In the longer surviving pigs of both groups 
either the graft or the host liver recovered. 
Processes that might be responsible for the observed hemodynamic changes 
and coagulation disorders are discussed. These results indicate that APLT 
is technically feasible in severely ill pigs with acute hepatic failure. 
101 
Introduction 
In patients with fulminant hepatic failure caused by massive 
hepatocellular necrosis orthotopic 
considered with a few exceptions1 . 
cirrhotic patients who receive 
liver transplantation is currently not 
Operative mortality rate in end-stage 
an orthotopic liver transplant in the 
period of acute hepatic decompensation may be as high as 80%, mostly due 
to severe bleeding and hypotension2 Removal of the host liver in an area 
of extensive venous collaterals accounts for most of the blood loss3. In 
auxiliary heterotopic transplantation for non-malignant liver disease, the 
basic surgery consists of three vascular anastomoses and restoration of a 
bile outflow tract after limited dissection; this technique may improve 
the discouraging results so ~ar obtained in patients with acute hepatic 
decompensation. The beneficial effect o~ auxiliary transplantation of 60% 
o~ a donor liver on host survival and hepatic metabolism in experimental 
animals that received a transplant before induction o~ liver ~ailure, has 
been demonstrated previously4 . 
In the present study we investigated the perioperative effects o~ 
auxiliary partial liver transplantation (APLT) on hemodynamics and 
coagulation status in pigs with fulminant hepatic failure, induced before 
the transplantation procedure. 
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Methods 
Pigs. In female Yorkshire pigs (28.0 ± 0.6 kg, mean± SEM) a side-to-side 
portacaval shunt, division of the hepatic 
was carried out. External vessel occluders 
ligaments and 
were applied 
cholecystectomy 
in the liver 
hilum around the hepatic artery and the portal vein (Fig.1A). Three days 
after this operation acute liver necrosis was induced by 6 hr occlusion of 
the hepatic artery and portal vein in the liver hilum, as described 
prev1ously4 • 
Two consecutive series of transplantations were performed. Our surgical 
technique of APLT has been described els.ewhere5 . At the end of the 
operation the vessel occluders were removed and the side-to-side 
portacaval shunt was abolished by placing two large hemostatic clips at 
the site of the anastomosis (Fig.1B). Truncal vagoto~~ and pyloroplasty 
were added to the surgical procedure. Transplantation in both groups was 
performed in donor-recipient combinations matched for the mixed lymphocyte 
reaction test; body weights of donor and recipient animals were similar. 
In the first group (n=11 ), animals received an auxiliary partial liver 
transplant 13 hr after induction of acute hepatic failure. In the second 
group (n=10), APLT was performed 3 hr after induction of acute liver 
failure. 
Anesthesia. After induction of anesthesia with small intravenous doses of 
ketamine chloride or thiopental, endotracheal intubation was performed. 
Anesthesia was maintained with nitrous oxide and oxygen (2:1) and minimal 
amounts of enflurane. The animals were paralysed with pancuroniumbromide 
and were ventilated using a Siemens 900B Servo ventilator. End-expiratory 
carbon dioxide was maintained between 4 to 5 volume %. Analgesia was 
supplemented with small doses of FentanylR. During the operation Ringer's 
solution, 0.9% NaCl, and HaemaccelR were given. Metabolic acidosis was 
corrected by administration of sodium bicarbonate. All recipient animals 
received 800 ml donor blood during surgery. 
clotting factors was administered to all pigs 
Fresh frozen plasma to supply 
during APLT. All animals 
received ampicillin (0.5g) and kanamycin (0.5g) intravenously at the 
beginning of surgery and immediately afterwards. 
drugs were given. 
No immunosuppressive 
A B 
occluder 
sensor 
Fig. 1. A. Schematic drawing of anatomy after portacaval shunt and 
occluders around hepatic artery and portal vein. 
B. Situation after APLT, and induction of host liver failure 
vc vena cava, HA hepatic artery, PV = portal vein, 
Ao aorta, Duod = duodenum, CBD = common bile duct. 
103 
Hemodynamic monitoring. In group I the arterial blood pressure was 
monitored by a catheter introduced into the carotid artery. In group II 
monitoring of the pulmonary arterial pressure, and the pulmonary capillary 
wedge pressure (PCWP) was added with the use of a Swan-Ganz catheter ; 
the cardiac output (CO) was measured by the thermodilution method6 . The 
systemic vascular resistance (SVR) was calculated with a computer program 
from the formula SVR = (mean arterial pressure - central venous pressure) 
x 80/CO and pulmonary vascular resistance (PVR) from PVR = (mean pulmonary 
pressure - PCWP) x 80/CO. The urine production was monitored during 
surgery and in the immediate postoperative period. 
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Coagulation monitoring. In group II NormotestR. activated partial 
thromboplastin time (APT:r), and fibrinogen level were measured. The 
coagulation 
surgery, 
pro:file was studied during host liver ischemia, during 
postoperative period using 
minimal two hours7 •8 (Fig.2). 
and in the immediate 
thromboelastography with whole blood during 
fibrinolytic activity 
A 
r k 
Fig. 2. Scheme of thromboelastogram. The time necessary for the 
initiation of clotting is referred to as the r-value (reaction 
time). After initiation of clotting the clot should reach a 
total amplitude of 20 mm in 2 to 8 minutes; this time is called 
the k-value (clot formation time). Total width of the clot is 
expressed as MA (maximum amplitude) which should reach a minimum 
o~ 50 mm. Fibrinolytic activity is measured by the decrease o~ 
MA in minimal t~o hours. 
Follow-up studies. Blood samples ~ere taken be~ore the first operation, 
before and after induction of ischemic hepatic necrosis, during the second 
operation, on the first day after liver transplantation and weekly 
thereafter. 
aminotransferase 
Hemoglobin, 
and gamma 
leukocytes. platelets, 
glutamyl transaminase 
serum aspertate 
~ere 
standard laboratory techniques. Intraveno-.J.s angiography 
determined by 
and 99mTc-HIDA 
scanning as described previously5 • were performed under general anesthesia 
in the second postoperative week. Liver biopsies of the host liver and 
the graft were taken at the end of the transplantation procedure and at 
autopsy. 
Statistical analysis. All data are expressed as mean values ± SEM. 
Statistical analysis was performed using the Student's t-test for paired 
and unpaired data; values for p < 0.05 are considered to be significant. 
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Results 
In group I (n=11) one animal died of liver insufficiency before liver 
transplantation could be performed 7 hr after induction of host liver 
ischemia. Two pigs died during the transplantation procedure of 
hypotension and ventricular fibrillation 6 and 9 hr after induction of 
acute liver failure. APLT was carried out in 8 pigs in group I. All 
animals in group II (n=10) received a heterotopically placed partial liver 
graft. 
MAP 
mm Hg 
100 
50 
0 
** 
** 
0 2 3 q 5 6 t 
Fig. 3. Mean arterial pressure in 8 animals of group I and in 10 animals 
of group II that underwent APLT (mean± SEM). 0 = pre-APLT; 
vena cava occlusion; 2 = vena cava and portal vein occlusion; 
3 graft reciculation; 4 clamp on aorta; 5 = clamp off aorta; 
6 end operation. p < 0.05, p < 0.01, *** p < 0.001, 
compared with group I. 
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Hemodynamics. In group I mean arterial pressure was significantly 
decreased at the beginning and during the second operation, compared to 
the pigs in group II that received large amounts of fluids (Fig. 3). 
Fluid substitution during APLT was 1.7 ± 0.2 Lin group I and 4.5 ± 0.3 L 
in group II. There was no difference in blood loss during surgery in 
group I and II (606.3 ± 81.0 ml and 735.0 ± 115 ml respectively). In all 
pigs in group II CO and PCWP decreased with 66% and 43% respectively 
during occlusion of the recipient vena cava and the portal vein (Fig.4). 
PCWP 
mm/hg 
10 
CO 1/min _,-_ _, r-..l PCWP 
5 7.5 
5 ;'t:E-*~*:........:;;~~**r:*~-s*~*---{ co *** J--..r., 
. -:!*** 
2.5 
0 
0 2 3 4 5 Sa 6 t 
Fig. 4. Pulmonary capillary wedge pressure (PCWP) and 
in 10 animals of group II that underwent 
cardiac output (CO) 
APLT (mean± SEM). 
0 : pre-APLT; vena cava occlusion; 2 = vena cava and portal 
vein occlusion; 3 = graft recirculation; 4 = clamp on aorta; 
5 = clamp off aorta; 5a end host liver ischema; 6 = end 
operation. * p < 0.05, ** p < 0.01 
preoperative values. 
*** p < 0.001 compared with 
CO remained decreased thereafter while the PCWP returned to normal. The 
SVR and the PVR increased with maximal 103% and 190% during APLT and 
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remained elevated in the immediate post operative period (Fig.5). The 
pressure in the recipient portal vein in group I and II animals was 17.1 ± 
1.3 mmHg before transplantation and decreased after recirculation of the 
transplant to 12.4 ± 2.2 mmHg (28% decrease). 
SVR 
-5 Dynes.sec.cm 
3000 
1500 
0 
PVR 
-5 Dynes.sec.cm 
400 l 
200 
0 
0 
~PVR 
2 3 4 5 Sa 6 t 
Fig. 5. Systemic vascular resistance (SVR) and 
resistance (PVR) in 10 animals of 
APLT (mean± SEM). See fig. 4 for 
group 
pulmonary 
II that 
vascular 
underwent 
• p < 0.05, p < 0.01 • 
explanation 
p ( 0.001 
of time points. 
compared with 
preoperative values. 
Coagulation profile. 
of the recipient 
0.01). In group II 
10.9 x 109/L (p 
In group I platelets decreased after 
liver from 268.8 ± 16.8 to 140.4 ± 22.2 
recirculation 
X 109/L (p < 
the platelets decreased ~rom 224.6 ± 19.2 to 83.8 ± 
< 0.01) after the end of host liver ischemia. The 
reaction time (r) and k-value of the thromboelastograms that are 
associated with clot formation increased with 53% and 174% respectively 
while the maximum amplitude, indicating clot stiffness. decreased with 31% 
after recirculation o~ the recipient liver, compared to preoperative 
levels (Fig.6). Hemoglobin content and hematocrit did not change 
significantly during the same period due to transfusion of blood. A 
further decrease in amplitude of the thromboelastogram, indicating 
enhanced fibrinolytic activity, was not noted after the end o~ host liver 
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ischemia. The NormotestR in group II decreased from 45-9 ± 5.6% before 
the transplantation to values below 5% in the four animals surviving 24 
hours. Fibrinogen level decreased from 1.7 ± 0.2 to 0.5 ± 0.2 gjL while 
APTT increased from 27.1 ± 1.9 to 39-4 ± 2.5 sec during the same period. 
In the 2 animals of this group that survived more than one week after APLT 
the thromboelastogram and values of the NormotestR, APTT, and fibrinogen 
became normal. 
Laboratory tests. In both groups there was a sharp rise in aspertate 
animotransferase level uptill hundred times normal values after 6 hours 
host liver ischemia. In the pigs that survived the first 2 days the level 
normalized almost completely within two weeks. A rise of bilirubin was 
also seen after induction of liver failure and the level remained slightly 
elevated in the animals surviving for longer periods after APLT. 
Survival. Three animals of group I died within 48 hr after the operation 
o! technical problems (portal vein thrombosis. air embolism) and one pig 
died of intraabdominal bleeding; in 2 other animals the cause of death 
could not be detected at autopsy. The remaining 2 pigs of this group both 
died of bleeding from a gastric ulcer 17 and 19 days after APLT. In group 
II, 2 pigs died within 2 days after APLT of intestinal strangulation or 
air embolism. Postoperative intraabdominal bleeding related to 
deficiencies in hemostasis caused the death of 6 other animals. Two pigs 
in this group survived in good health untill death at 12 and 42 days after 
the operation because of host liver suppuration. 
In the 4 animals that survived the immediate postoperative period, 
histological examination showed more than 75% hepatocellular necrosis in 
recipient livers at the end of the transplantation procedure. In group I 
the grafts at autopsy in the 2 longer surviving pigs appeared to be almost 
completely necrotic with severe inflammatory infiltrates. In one of these 
pigs the portal vein was occluded but the other vascular and bile duct 
anastomoses were patent. The host liver in these animals appeared to be 
recovered almost completely from the previous ischemic period. The 
transplants of the 2 pigs in group II at autopsy examination were 
virtually normal at macroscopic inspection and all anastomoses were 
patent. Histological examination showed mild cholangitis and inflammatory 
infiltration of round cells and polymorphonuclear leukocytes. Slight 
hepatocellular necrosis of less than 10% was seen in these grafts. In 
contrast to the findings in the 2 long survivors from the first group, 
subtotal liver necrosis was demonstrated in the host liver of these 2 
pigs. 
In both groups the results of hepatobiliary scintigraphy of 
T.V.-angiography in the second postoperative week were consistent with the 
findings at autopsy examination. 
Hb g% 
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Fig. 6. Hemoglobin level, r-value, k-value, and maximum amplitude of 
thromboelastogram in 10 animals that underwent host liver 
ischemia and APLT (mean± SEM). * p < 0.05, p < 0.01, 
*** p < 0.001 compared with preoperative values. 
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Discussion 
In previous APLT experiments ve used recipient animals that were healthy 
at the time o~ operation4 •5 •9 . Although sufficient metabolic support of 
the transplant in the event of host liver failure could be demonstrated4 , 
problems resulting from end-stage liver disease at the time of the 
transplantation procedure had not been studied. In the present study a 
different experimental design was used to imitate the clinical situation 
in man, in which problems concerning hemodynamics and hemostasis could be 
investigated. The severity of fulminant hepatic failure in our model was 
reflected by the poor condition of the animals at the time of 
transplantation as 
before or shortly 
death o~ 3 animals evidenced by hypotension and the 
after induction o~ anesthesia. Fulminant hepatic 
severe coagulopathy. ~ailure in 
Coagulopatb.y 
man is invariably 
of hepatic ~ailure is 
associated with 
explained by thrombocytopenia, failure 
o~ synthesis o~ clotting ~actors and consumption coagulopathy as direct 
consequence o~ liver cell necrosis10 . 
Reported models so ~ar used in liver transplantation experiments do not 
re~lect the problems encountered in patients with ~ulminant hepatic 
~ailure 11 . Liver transplantation has been evaluated in pigs with 
~ulminant hepatic ~ailure induced by Amanita phalloides toxin12 . In that 
study hemorrhagic diathesis was only encountered in 3 out of 21 animals 
which is in 
~ailure 13 . 
contrast to ~indings in 
Auxiliary liver 
patients with fulminant hepatic 
transplantation for 
dimethylnitrosamine-induced acute hepatic failure has been per~ormed by 
Kuster without hemorrhagic complications14 . Drug induced hepatic 
insu£~iciency, however, bas the disadvantage o~ low reproducibility and 
there~ore may explain the reported ~avorable results 15 . Temporary 
auxiliary liver transplantation in acute liver failure, induced by one 
hour host liver ischemia has been, described in dogs 16 The transplant 
was positioned in the thorax and removed on the 5th postoperative day. 
Although the time needed ~or host liver recuperation in the latter study 
seems to be very short, 2 dogs survived 10 and 15 days. Severe 
hemorrhagic diathesis was absent in this experiment and the period of 
hepatic support very short; nevertheless it was suggested that the 
temporary auxiliary liver transplant is capable o~ supporting life during 
acute hepatic injury in the dog. Huguet, however. did not observe 
reversal o~ encephalopathy by an auxiliary liver transplant in pigs with 
induced host liver ischemia17 . In his study severe disseminated 
intravascular coagulation was noted and no animals survived more than 9 
hours. 
In our study acute hepatic ~ailure was also produced bY means o~ temporary 
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ischemia. Hemodynamic changes and coagulation disorders developed that 
resembled the syndrome of fulminant hepatic failure in man. In the pigs 
in which acute liver failure was induced 13 hr before surgery (group I), 
the condition of the animals became very poor. Most animals were 
hypotensive at the start of surgery and perioperative mortality was high. 
Fluid administration of a mean 1.7 L per animal did not improve the blood 
pressure in the animals of group I. Fresh frozen plasma was also 
administered routinely during transplantation and prevented major bleeding 
problems during surgery in this group, although low blood pressure 
probably obscured manifestation of clotting disorders. 
In an attempt to improve results of APLT in these severely ill pigs the 
time interval between liver ischemia and the transplantation was reduced 
to three hours (group II), and anticipation of hemodynamic changes was 
attained by the use of a flow-directed baleen-tip pulmonary artery 
catheter. As a result of this approach the condition of the animals in 
group II improved as was reflected by the higher 
at the start of surgery and throughout the 
arterial blood pressure 
second operation. A 
significant decrease in arterial blood pressure, CO and PCWP was noted 
during total obstruction of recipient hepatic flow and occlusion of 
inferior vena cava. Decrease in systemic blood pressure is well known 
after interruption of hepatic bloodflow18 • 19 •20 , and has been observed 
previously by our group21 In the previously reported experiments of 
auxiliary liver 
failure14,16,17,22, 
transplantation 
no study has 
in the presence 
been performed to 
hemodynamic changes during the transplantation procedure. 
o£ liver 
evaluate the 
The occurrence of hypotension in fulminant hepatic failure is well 
recognised, although pathogenesis remains obscure23 •24 . It has been 
suggested that central vasomotor depression is more important than primary 
heart failure25. Our study has demonstrated that large amounts of fluid 
were necessary to maintain PCWP at near normal levels following graft 
recirculation. In spite of this, CO was markedly lower than normal while 
at the same time SVR was increased. This indicates a primarily myocardial 
depression following reinstatement of blood flow through the donor liver, 
with subsequent release of toxic substances like oxygen free radicals from 
the ischemic liver or splanchnic region as has also been suggested by 
others26 •27 •28 . Administration of serum, obtained immediately after 
recirculation of the ischemic host liver, to an in-vitro beating rat heart 
model caused cessation of cardiac contractions (unpublished observations). 
Consequent hypotension was partially compensated by massive increase of 
SVR. Recirculation of the host liver after 6 hours ischemia did not 
result in further decrease of CO. However, at this point large quantities 
of sodium bicarbonate were administered to counteract the ensuing 
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metabolic acidosis and the heart action was stimulated with calcium 
chloride, thus obscuring possible negative effects of toxic substances on 
myocard function. In future experiments it may be possible to increase CO 
by the judicious use of vasodilators and positive inotropic agents. 
Increase of PVR in this study after APLT is an interesting observation. 
It might be partly due to intravascular coagulation a£ter host liver 
recirculation. Furthermore, reperfusion of the host liver a£ter an 
ischemic period stimulates thromboxane A2 release which in association 
with thromboemboli results in constriction of smooth muscle around the 
pulmonary vasculature27 Fluid overload was not the cause of increased 
PVR, as PCWP remained mainly ~hi thin normal limits. 
In this study we ~ound an elevation o~ the portal venous pressure after 
the temporary ischemia to 17.1 ± 1.3 mm Hg, normal values in the 
anesthetised pig being 3-7 mm Hg. This finding is in accordance with 
observations in patients with acute liver failure29 . Portal venous 
pressure decreased with 28% after recirculation o~ the graft. This 
indicates that the graft ~unctions as a portacaval shunt. Ligation o~ the 
after APLT as we performed in previous recipient's portal vein 
experiments4 , there~ore, is not indicated in the presence of a diseased 
host liver. 
Thromboelastography was used 
Zuckerman and co-workers 
to 
found 
evaluate the 
a striking 
coagulation 
correlation 
profile. 
bet~een 
thromboelastographic parameters and standard laboratory coagulation 
tests30 . Severe clotting disorders were seen immediately after the end of 
host liver ischemia in the second series of experiments. Prolonged clot 
~ormation time ~as demonstrated by increased r-values and k-values of the 
thromboelastograms. Decrease in maximum amplitude is explained by the 
sharp reduction in platelets count observed at the end o~ host liver 
ischemia. The hemoglobin level and hematocrit did not alter during the 
changes in thromboelastographic parameters: hemodilution as an 
explanation for the observed findings is thus less likely. Abnormalities 
in coagulation profile after recirculation o~ the ischemic liver parallel 
clinical findings. Major blood loss from the plane o~ resection of the 
graft nor ~rom vascular anastomoses ~as noticed prior to host liver 
recirculation. However, as soon as occluders on the portal vein and 
hepatic artery o~ the host liver were removed and the host liver was 
reperfused, oozing o~ blood occurred. This phenomenon ~as not observed 
after permanent occlusion of the blood inflow to the host liver in another 
series of experiments (unpublished observations). Intravascular 
coagulation in the ischemic damaged host liver likely explains coagulation 
disorders. 
radicals 
Other 
after 
investigators suggest the release of 
organ ischemia31 . Subsequent 
oxygen-derived free 
tissue damage and 
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intravascular coagulation with depletion of clotting factors could be an 
explanation of the observed bleeding at anastomotic sites. The 
substitution of fresh blood from the donor animal and fresh frozen plasma 
could not prevent postoperative mortality from hemorrhagic complications 
in group II. Platelets to correct low levels were not available. In the 
animals that survived the immediate postoperative period with severe 
clotting abnormalities, synthesis of clotting factors by the transplant 
and the production of platelets by the bone marrow resulted in a normal 
coagulation profile. 
The pigs in group I surviving more than 2 weeks after transplantation had 
a necrotic transplant at the time of death. As biopsies of the host liver 
in these pigs showed subtotal necrosis at the time of operation, the liver 
grafts supported the animals only during the period of host liver 
recovery. The reason for graft failure in these pigs is not clear; 
failure caused by a technical problem is less probable in view of the 
findings at autopsy examination. In group II the host liver in the two 
longer surviving animals was transformed in a flat fibrotic structure, 
while the graft had increased in size considerably. The grafts supported 
these pigs completely as the host liver did not recover function. As time 
interval between induction of liver failure and APLT was reduced from 13 
hr (group I) to 3 hr (group II), difference in graft survival between the 
animals of both groups as result of this measure can not be ruled out. 
The observations in the longer surviving animals of both groups tend to 
support the concept of 'functional competition' between host liver and 
graft as has been suggested by Vander Heyde and co-workers32 . 
In summary, we found that hypotension in these very ill animals could be 
partly prevented by reduction of the time interval between liver failure 
and APLT and by massive fluid replacement. Problems in hemostasis are 
caused by consumptive coagulopathy rather than fibrinolysis. We 
demonstrated that APLT is technically feasible in these severely ill pigs 
with acute hepatic failure. Interestingly enough, in the longer surviving 
pigs either the graft or the host liver recovered. The underlying 
biochemical processes that are ~esponsible for survival of one of the two 
livers need to be elucidated. It seems justified to further explore the 
possibilities of APLT as support system in liver failure in experimental 
and clinical studies. 
114 
References 
1. 
2. 
National Institutes of Health consensus 
statement: Liver transplantation. 
1078-108. 
Pichlmayr R. BrOlsch Ch, Wonigeit K, et 
liver transplantation in Hannover. 
56S-60S. 
development 
Hepatology 
con:f'erence 
1984; 4: 
al. Experiences 
Hepatology 1984; 
with 
4o 
3. Goldsmith MF. Liver transplantation: big business in blood. 
4. 
5-
6. 
JAMA 1983; 250: 2904-5. 
Reuvers CB, Terpstra OT, Boks AL, et al. Auxiliary 
transplantation o£ part o£ the liver improves survival and 
provides metabolic support in pigs with acute liver failure. 
Surgery 1985; 9So 914-21. 
Reuvers CB, Terpstra OT, 
survival of auxiliary 
pigs. Eur Surg Res, -in 
ten Kate 
partial 
press-
FWJ, et al. Rejection and 
liver graft in non-tissue-typed 
Ganz W, Swan HJC. 
Am J Cardiel 1972; 
Measurement of blood flow 
29: 241-46. 
by thermodilution. 
7. Vreeken ~- ThromOoelastografie. Thesis, University of 
s. 
Amsterdam, 1957. 
Howland WS, Ryan GM, Bettigole 
abnormalities associated with 
1970~ 68: 591-6. 
RE, Fortner JG. Coagulation 
liver transplantation. Surgery 
9. Reuvers CB, Terpstra OT, ten Kate FWJ, Kooy PPM, Molenaar JC, 
Jeekel J. Long-term survival of auxiliary partial liver grafts 
in DLA-identical littermate beagles. Transplantation 1985; 39: 
113-8. 
10. Jones EA, Schafer DF. Fulminant hepatic failure. In: Zakim D, 
Boyer T, eds. Hepatology. Philadelphia: WE Saunders, 1982: 
415-45. 
11. Tygstrup N, Ranek L. 
Gastroenterol 1981; 10: 
Fulminant hepatic failure. 
191-08. 
Clin in 
12. H5kl J, Koristek V, Cerny J, Gregor Z, Filkuka J, Busch K. 
Orthotopic allotransplantation of liver in pigs with fulminant 
hepatic failure. Transplantation 1980; 29: 424-25. 
13. Flute PT. Blood coagulation defects 
failure. Am J Gastroenterol 1978; 69: 
in fulminant 
363-5-
hepatic 
14. Kuster GGR, Woods JE. Auxiliary liver transpl~~tation in the dog 
ll5 
as temporary support in acute fulminating hepatic necrosis. Ann 
Surg 1972; 176: 732-5. 
15. Ouchi K, NoseY, Hermann RK. Surgically induced hepatic failure 
in animals. Cleveland Clin Quart 1977; 44: 171-80. 
16. Diaz A, Ricco JB, Franco D, Gigou M, Szekely AM, Bismuth H. 
Temporary liver transplantation in acute liver failure. Arch 
Surg 1977; 112: 74-8. 
17. Huguet C, Bloch P, Opolon P, et al. 
aigues du fois par transplantation 
108: 397-06. 
Traitement 
hepatique. 
d;e necroses 
J Chir 1974; 
18. Fredlund PE, Ockerman PA, Vang JO. 
plasma levels of B-D-glucosidase, 
hepatic inflow occlusion in the pig. 
234-41 . 
Acidosis and increased 
and B-D-galactosidase after 
Acta Chir Scand 1974; 140: 
1 9. Battersby 
:!:"unction 
ischemia. 
C, Hickman R, Saunders SJ, 
in the pig: The effects of 
Br J Surg 1974; 61: 27-32. 
Terblanche 
30 min. 
J. Liver 
normothermic 
20. De Lange JJ. Reitsma HFW, Meyer 
experimental orthotopic liver 
SurgRes1984; 16: 360-5. 
S. Anaesthetic management 
transplantation in the pig. 
in 
Eur 
21. De Groot GH, Reuvers CB, Schalm SW, et al. A reproducible model 
of acute hepatic failure by transient ischemia in the pig. J 
Surg Res, -in press-. 
22. Lilly JR, Anderson KD, Hill JL, 
Auxiliary liver transplantation in 
Pediatr Surg 1972; 7: 492-8. 
Basser 
acute 
SB, Randolph 
liver failure. 
JG. 
J 
23. Ritt DJ, Whelan G, Werner DJ, Eigenbrodt EH, Schenker S, Combes 
B. Acute hepatic necrosis with stupor or coma. An analysis o£ 
31 patients. Medicine (Baltimore) 1969; 48: 151-72. 
24. Rue££ B, Benhamou JP. Acute hepatic necrosis and £ulminant 
hepatic £ailure. Gut 1973: 14: 805-15. 
25. Trewby PN, Williams R. Pathophysiology of hypotension in 
patients with £ulminant hepatic failure. Gut 1977; 18: 1021-6. 
26. Le£er AM. The pathophysiologic role o£ 
£actor as a mediator or circulatory shock. 
60: 713-6. 
27. Mathieson MA, Dunham BM. Huval WV, et al. 
stimulates thromboxane 
Surg Gynecol Obstet 1983; 
production and 
157: 500-4. 
myocardial depressant 
Klin Wochenschr 1982; 
Ischemia of the limb 
myocardial depression. 
28. Bulkley GB. The role o£ oxygen £ree radicals in human disease 
processes. Surgery 1983; 94: 407-11. 
116 
29. Lebrec D, Nouel o. Bernuau 
hypertension in fulminant 
962-4. 
J, Rueff B, Benhamou 
viral hepatitis. Gut 
JP. Portal 
1980; 21: 
30. Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. 
31. 
Comparison of thromboelastography with common coagulation tests. 
Thromb Haemostas 1981; 46: 752-6. 
Parks DA, Bulkley 
shock, ischemia, 
428-32. 
GB, Ganger DN. Role of oxygen free radicals in 
and organ preservation. Surgery 1983; 94: 
32. Van der Heyde MN, Schalm L, Vink M. The role of functional 
competition in auxiliary liver transplantation. Transplantation 
1967; 5: 78-9. 
CHAPTER 7 
General discussion and conclusions 
7.1 Rationale of the study 
As an adequate artificial system to support a patient with end-stage liver 
disease does not exist1 • the solution for these patients could be 
transplantation of a new liver either orthotopically, i.e. by complete 
replacement of the original organ, or heterotopically without removal of 
the host liver. Hepatocellular transplantation where liver cells are 
transplanted as free grafts has been used in the treatment of acute 
hepatic failure in rats2 •3 •4 . This technique is theoretically attractive 
to support the diseased liver, because it is relatively simple. However, 
favourable results so far have only been obtained in rats, where liver 
failure was induced by dimethylnitrosamine, galactosamine or by a surgical 
procedure that was preceeded or accompanied by hepatocellular 
transplantation. Instead of being used for support in acute hepatic 
failure or end-stage chronic liver disease, liver cells transplanted as 
free grafts might supply an enzyme that is congenitally deficient. Matas 
and others suggested that isolated liver cells or small pieces of normal 
liver tissue transplanted as free grafts could supply the enzyme bilirubin 
uridine diphosphate glucuronyl transferase to Gunn rats5 • 6 . These rats 
exhibit unconjugated hyperbilirubinemia due to a heriditary absolute 
deficiency of bilirubin uridine diphosphate glucuronyl transferase 
activity. Others, however were unable to confirm these reports and 
demonstrated disappearance of the transplanted tissue in a short period of 
time7 . There are no reports of successful liver cell transplantation in 
large animal models or patients. Therefore liver transplantation using 
vascularized grafts is, at the present, the only therapy for liver 
failure, that can offer good results both clinically and experimentally. 
In the case of end-stage chronic liver disease in man orthotopic liver 
transplantation is the technique performed by all liver transplantation 
groups and one-year survival now approaches 70% in selected 
patients8 • 9 • 10 .For malignant disease of the liver removal of the host 
liver is obviously essential. Long-term results in liver transplantation 
patients in whom a malignancy of the liver formed the indication for 
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transplantation are 
?o%9 • 11 • Advanced 
still poor with a tumor recurrence rate o~ more than 
stage of the tumor at the time of transplantation or 
growth of residual tumor expedited by immunosuppressive therapy might be 
an explanation for the high recurrence rate. For non-malignant 
parenchymatous liver disease there are advantages of an orthotopic liver 
transplant over an auxiliary liver graft. There is room to accomodate the 
transplant and the vascular and bile duct anastomoses lie in correct 
anatomical position to each other. However, resection of the patient's 
own liver, often in a~ area with venous collateral blood vessels, is a 
major procedure that induces substantial blood loss during 
operation10 • 12 • 1'. At Pittsburgh university hospital a mean of 42 units 
o£ red blood cells, 39 units o£ £resh £rozen plasma, 19 units o£ 
platelets. and 8 units o£ cryoprecipitate were required per patient 
between 1981 and 198312 . I£ serious coagulation disorders are present, as 
is the case in advanced stages o£ chronic liver failure or in acute liver 
insu££iciency, requirements will be even higher and orthotopic liver 
transplantation is not a realistic solution. In such patients where 
severe problems with hepatectomy can be anticipated auxiliary liver 
transplantation o££ers an alternative. However, experience with clinical 
auxiliary liver transplantation so £ar has not been encouraging as 
outlined in Chapter 1.3. The aim o£ our experiments was to £urther 
evaluate the surgical technique o£ auxiliary liver transplantation and its 
feasibility in the presence of acute host liver failure. 
7.2 Surgical technique 
In our experiments a technique o£ auxiliary liver transplantation was 
developed where all theoretical requirements for optimal graft function as 
outlined in Chapter 1.5 were met. In our series we used only partial 
liver grafts. The use of reduced size grafts offered a solution to space 
related problems as no difficulties were encountered in wound closure. 
Respiratory problems 
others 14 , were not 
caused 
seen in 
by the size of the graft as reported by 
our experiments. Transplantation of 
reduced-size adult liver grafts has been successfully performed in 
patients as well in the orthotopic ae in the heterotopic position15 . 
However, the use of partial liver grafts raises several technical 
problems. The period necessary to reduce the size of the graft will 
increase ischemia time. If cooling is continued 
hepatectomy on the bench and the time required 
during the partial 
for the actual 
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transplantation of the host liver is short, this increased ischemia time 
probably will have no harmful effects16 . Bleeding from the transected 
liver surface is another problem that might be expected with the use of 
partial liver grafts. Our solution has been meticulous ligation of all 
visible vessels and bile ducts in 
continuous polydiaxanon (EthiconR) 
combination with compression by a 
suture. Application of rapid 
polymerizing glue or cyanoacrylate on the transected liver surface as an 
additional procedure to ligation of all structures during transection of 
the donor liver has been used by others15 • 17 . Ultra sonic dissection that 
has recently been introduced in liver surgery seems to facilitate hepatic 
transection18 • It will be worthwhile to evaluate this technique during 
bench surgery in auxiliary partial liver transplantation. 
In order to avoid atrophy of the transplant and problems with the biliary 
anastomosis it is important to have portal and arterial blood flow to the 
graft as previously discussed in Chapter 1 .5. Low outflow pressure in the 
hepatic veins of the graft is also essential to avoid graft damage19 • All 
these criteria were easily met by our technique where the graft is placed 
in the right upper part of the abdomen. The reduced size of the grafts we 
used, facilitated placement in this position. Reconstruction of the 
biliary outflow tract of the graft was performed in the dog by 
choledochoduodenostomy using a pull through technique. This method copied 
from liver transplantation experiments in rats. proved to be an adequate 
technique in the dog where the common bile duct is relatively sma1120 . 
Anastomotic obstruction was only seen once in our study. In the pig 
choledochoduodenostomy was used as bile drainage procedure. De Jonge 
recently reported on three different biliodigestive anastomoses in the 
pig21 During a follow up period of three months he found no 
statistically significant differences in the incidence of cholangitis, 
leakage or stenosis between a direct choledochoduodenostomy. Roux-en-Y 
choledochojejunostomy. or choledochoduodenostomy with an anti-reflux 
procedure. Choledochoduodenostomy never resulted in bile le~~age or 
stricture formation in our series. Of the various options. reconstruction 
of the biliary tract with the use of a jejunal Roux-en-Y loop should be 
considered in the case of auxiliary liver transplantation in man. This 
reconstruction will prevent or reduce the incidence 
cholangitis22 Furthermore, the Roux-en-Y loop has 
of ascending 
proven to be 
satisfactory in orthotopic liver transplantation in cases of biliary 
atresia and disorders in which the recipient common bile duct was 
inadequate23 
Decompression of the portal vein and inferior vena cava during clamping at 
the time of construction of the venous vessel anastomoses was not used in 
our experiments. Although a drop in blood pressure was usually seen 
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during this period, the majority o~ animals recovered soon afterwards. 
Pump driven vena-venous bypasses to shunt blood ~rom the lower to the 
upper half of the body, that are currently used in orthotopic liver 
transplantation8 , are unnecessary in auxiliary liver transplantation as 
the time of portal outflow occlusion is short and decompression will occur 
by the collateral pathways. 
7.~ Regeneration 
Resection of part of the transplant may result in release of factors which 
have been implicated as important promoters of regeneration24 •25 . Such 
factors may stimulate hepatocyte proliferation and help to restore liver 
mass during the regenerative process in a diseased host liver. Host liver 
regeneration following ischemic liver damage was not observed 
histologically in the pigs that received a transplant prior to liver 
failure (Chapter 5). DNA and RNA contents of recipient livers in that 
experiment decreased significantly whereas hyperplasia of the liver 
transplant was suggested at the same time. However, in the experiments 
performed on pigs that received a graft after induction of recipient liver 
failure, host liver regeneration was indicated in two animals (Chapter 6). 
In the latter experiment host liver regeneration, however, was not seen in 
two other long surviving animals. Therefore, one has to conclude that the 
supposed positive influence of an auxiliary partial liver graft on host 
liver regeneration was not a consistent finding in our experiments. 
With our technique the recipient liver received no portal blood in all 
experiments where recipient livers were not damaged by ischemia at the 
time of transplantation. This ensured optimal portal blood flow 
the graft. In the clinical situation there will usually exist 
hypertension as a result of host liver disease26 , and ligation 
through 
a portal 
of the 
portal vein will probably not be necessary as the portal blood will flow 
mainly through the graft. In the experiments described in Chapter 6 a 
decrease in portal pressure was indeed found after transplantation in the 
presence of host liver failure. This suggests that the graft functioned 
as a portacaval shunt. If the host liver recovers, this will most likely 
result in shifting of the portal blood stream from the transplant to the 
host liver. Should the host liver not recover, than the graft could 
become -non-auxiliary- as time passes with atrophy of the recipient liver 
and hyperplasia of the graft. This was the case in the experiments 
described in Chapter 5 and has also been reported in the two long-term 
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survivors of heterotopic liver transplantation in man14 •27 . Liver cell 
regeneration evidenced by increased DNA synthesis and mitoses has been 
reported in patients dying from fulminant hepatitis28 . The fact that 
patients with acute hepatic failure die despite demonstrable regeneration 
implies that the rate of liver cell necrosis is higher than of cell 
renewal. In the presence of an auxiliary partial liver transplant there 
will be more time available for hepatic regeneration. However, 
immunosuppressive medication will be essential in the case of liver 
allotransplantation and this might again impair proliferation activity in 
the host liver29 •30 . If total host liver regeneration nevertheless 
occurs, withdrawal of immunosuppression can be considered. 
7.4 Functional competition 
Vander Heyde and co-workers suggested that '£unctional competition' 
exists between the host liver and a liver graft in the case o£ auxiliary 
liver transplantation31 . He showed that auxiliary liver grafts could only 
survive i£ the recipient's liver was handicapped and that grafts would 
atrophy in the presence o£ a normal host liver. His study was carried out 
in dogs that received a transplant with arterial blood supply only. In 
that experiment atrophy o£ the graft could be prevented by construction o£ 
an end-to-side portacaval shunt to the recipient liver and ligation o£ the 
recipient hepatic duct. Portal venous blood in£low did not seem to be a 
prerequisite for transplant preservation in that study. The absence of 
severe rejection was remarkable as non-matched donor-recipient 
combinations were used. At variance with the results o£ van der Heyde and 
co-workers. we did not see in our experiments atrophy o£ the graft without 
histological signs o£ acute or chronic rejection. In the dog experiments 
(Chapter 2) the handicap to the host liver was the deprival o£ portal 
blood. Nevertheless. long-term gra£t survival after auxiliary liver 
transplantation untill 182 days was seen in the DLA-matched combinations. 
Rejection o£ the gra£t at the end of the experiment was more prominent 
than atrophy. Prolonged functioning of an auxiliary liver 
the presence of a normal host liver only deprived of portal 
transplant in 
blood has also 
been demonstrated several times in the experiments carried out in 
non-tissue-typed pigs (Chapter 3). In the study where both the liver 
transplant and the recipient liver received portal blood, 
liver recovery after a functional handicap consisting 
ischemia. was seen twice (Chapter 6). The host liver 
complete host 
of temporary 
in these pigs 
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recovered despite of the functional handicap and this would not be 
expected in view of the concept of 'functional competition'. Competition 
between host liver and graft is hard to define in biological terms. The 
presence or absence of portal blood with 'hepatotropic factors' essential 
for the integrity of the liver might be more important in respect to graft 
survival than the condition of the host liver32 • Hormones and nutrients 
carried to the liver by the portal vein are important to prevent liver 
atrophy as has been emphasized by various studies33 •34 •35 . Among the 
hormonal regulators affecting liver integrity and regeneration are insulin 
and glucagon36 . It has recently been suggested that hormone receptors 
present on the liver cells play an important role after induction of 
hepatic regeneration37 . The extensive and sometimes contradictory 
findings concerning hepatotropic factors so far reported in the literature 
indicate that the control of hepatic integrety and regeneration is a very 
complex and multifactorial process33 . In human liver transplantation 
there usually exists end-stage host liver disease and competition for the 
hepatotropic factors will probably be less as the portal blood flow under 
those conditions will be directed mainly to the graft. If however 
auxiliary liver transplantation is to be used for correction of an inborn 
error of metabolism in a liver with viable hepatocytes. the liver that has 
first access to the beneficial hormones in the effluent pancreatic and 
splanchnic venous blood probably will be at an advantage over the other. 
In that case ligation of the portal vein to the host liver should be 
considered. 
7.5 Rejection 
Cell-surface antigens located on normal nucleated cells will stimulate a 
rejection response when presented to an allogeneic recipient. 
Nevertheless a transplanted liver appears to behave different in some 
species than for instance the kidney. Livers transplanted between pigs 
genetically dissimilar to one other were rejected less vigorously than 
expected as was demonstrated by 
transplantation experiments3S.39. 
different workers in orthotopic liver 
It has been suggested that liver 
transplants in some species may provoke specific reduction of the immune 
response40 . Recent observations in patients that received an orthotopic 
liver transplant show that arterial thickening typically indicating 
chronic rejection is seen in liver grafts41 . So the liver transplanted in 
the orthotopic position generates a rejection reaction albeit perhaps 
123 
somewhat milder than encountered in other transplanted organs. Blood 
group compatibility is usually secured in clinical orthotopic liver 
transplantation. Successful transplants in the presence of blood group 
incompatibility, however, have been reported and very rapid rejection, 
within hours, 
the liver42 . 
immunological 
as seen in kidney transplants is rare or non-existent for 
This suggests that the transplanted liver induces an 
reaction, that is less severe than encountered after 
transplantation of other organs. Alternatively, it is conceivable that 
the liver is less vulnerable to rejection than other organs (while evoking 
a similar immune response) 43 . Rejection in auxiliary liver 
transplantation has been studied less extensively. Given the wide 
variations in operative techniques used in the different studies and the 
problems with the assessment of rejection, evaluation is difficult. 
Rejection after human auxiliary liver transplantation seems to have played 
a minor role in the therapeutic failures reported44 . We demonstrated that 
the auxiliary graft is subject to rejection. Severe acute rejection was 
seen in our experiments in non-tissue-typed dogs in spite of 
immunosuppressive medication (Chapter 2). The transplanted liver appeared 
to behave differently in non-tissue-typed pigs where acute rejection could 
not be demonstrated although no immunosuppressive medication was used 
(Chapter 3). An accidental match between donor and recipient in that 
experiment could not be excluded as tissue-typing was not performed. 
Auxiliary liver grafts, however, seem to be less subject to acute 
rejection in the pig than in the dog, and this is in accordance with 
observations in experimental orthotopic liver transplantation~8 . 
It has been suggested that the reticuloendothelial system of the liver 
participates in graft rejeetion45 . The presence of a healthy host liver 
with an intact reticuloendothelial system may lead to a stronger 
immunological attack on the graft than will be the case in the presence of 
host liver disease46 .If auxiliary liver transplantation is to be used in 
the presence of severe host 
liver in rejection might be less 
liver disease the role of 
significant. In our 
the recipient's 
study in dogs 
(Chapter 2) long-term graft survival was observed in DLA-matched dogs that 
received immunosuppression. The influence of the intact 
reticuloendothelial system of the host liver in that experiment was not 
specifically studied but appeared not to prevent graft survival. 
In our experiments graft survival might have been improved by blood 
transfusion as all recipient animals received a blood transfusion on the 
day of transplantation with blood from the donor animal. In renal 
transplantation it has been documented that there is an association 
between blood transfusions given to patients with renal failure during 
pretransplantation waiting periods or on the day of transplantation. and 
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improved graft surv1val of cadaver1c renal allografts47 •48 In orthotopic 
liver transplantation or auxiliary 
date scarcely 
upon graft 
available concerning 
survival43 . This 
experimentally and clinically. 
liver transplantation information is to 
the influence of blood transfusion(s) 
should be further examined both 
In the dog matching for histocompatibility antigens appeared to improve 
auxiliary liver graft survival considerably (Chapter 2), as was also shown 
for orthotopic liver grafts in dogs49 • 50 . Because of donor shortage, time 
limits of liver preservation, and urgent recipient need. matching for the 
antigens of the major histocompatibility complex will not be easy in the 
clinical situation. To date, experience in orthotopic liver 
transplantation has shown no relationship between the degree of matching 
and results. As most patients received a poorly matched liver41 .51 , the 
potential advantages of histocompatibility antigen-matching is difficult 
to assess in clinical liver trans~lantation. 
7.6 Immunosuppression 
All methods to prevent or reverse rejection of liver transplants are based 
on experience in renal transplantation. Double-drug therapy with 
azathioprine and steroids was used most frequently 
dog experiments. With 
50% can be obtained 
in liver 
this regimen 
after human 
transplantation as we did in our 
one-year survival rates exceeding 
orthotopic liver transplantation10 • Anti lymphocyte globulin resulting in 
lymphoid depletion has also been given as an adjunct to azathioprine and 
prednisone during the first few weeks or months when the risk of rejection 
is the greatest9 •41 • Cyclosporin A, a fungus extract which depresses 
humoral and cellular immunity, appeared to 
or delaying rejection of kidney grafts 52 . 
be very effective in preventing 
Introduction of cyclosporin A 
in orthotopic liver transplantation did not lead to a significant 
improvement in survival in the patients treated by the Cambridge group 53 . 
This is in contrast to the report from Starzl and co-workers who claimed 
that the use of cyclosporin A and steroid therapy, starting a few hours 
preoperatively, leads to better results compared to 
immunosuppression8 . When patients transplanted in 
conventional 
the major 
transplantation centers, who received cyclosporin A are compared with 
those who did 
liver graft 
not, no significant 
surviva1 54 . This 
difference is observed in orthotopic 
that other factors as better 
patient selection and 
suggests 
modification of technique contributed to the 
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improved graft survival rates after introduction of cyclosporin A. 
Nevertheless, cyclosporin A may prove to have special value in young 
patients. If the use of cyclosporin A leads to a concomitant reduction of 
steroid dosage then steroid induced growth retardation could be less as 
shown in pediatric liver transplantation23 •55 . Hepatotoxicity of 
cyclosporin A has been described. It is, however, rather infrequent and 
tends to be mild and reversible56 . Cyclosporin A has to date not been 
used ·in clinical or experimental auxiliary liver transplantation and it 
may be a subject for further study to investigate if this drug is superior 
to conventional treatment in heterotopic liver transplantation. 
7.7 Diagnosis of rejection 
Clinically the diagnosis of rejection is difficult and is often made by 
the exclusion of other reasons for graft dysfunction. Discrepancies exist 
in the histologic description of 
the appearance of acute and 
rejection, particularly in reference to 
chronic forms 57 . Early reports based on 
experimental studies are confusing as technical complications played an 
important role and acute and chronic rejection are usually ill-defined. 
Biliary obstruction and/or cholangitis may be the result of rejection or 
be secondary to complications in surgical technique. In our study 
differentiation of hepatic rejection into an acute or chronic form on 
histological criteria is a rather artificial one. Predominance of 
vasculitis and polymorphonuclear infiltration in portal triads was defined 
as acute rejection. In dog experiments this has been reported as to 
represent the earliest manifestations of rejection58 . Loss of small 
interlobular bile ductules associated with pseudo bile duct formation and 
round cellular portal infiltrates was thought to be present in the case of 
chronic rejection. Difference in morphology, however, between the acute 
and chronic lesions is sometimes not very clear and the pattern even 
becomes more complex in the case of biliary obstruction or ascending 
cholangitis. In the clinical situation viral liver infections, drug 
induced hepatitis, and recurrence of the 
lead to interpretational problems57 
primary liver disease may further 
Final interpretation of the 
histologic specimen has to be correlated with other data available at the 
moment of the biopsy. 
Biochemical and hematological changes that occurred in this study in the 
postoperative period in animals with a healthy recipient liver were not 
valid as index of graft viability or rejection. 
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Cholescintigraphy enabled us to assess graft function in a non-invasive 
way and in the presence of a healthy recipient liver. Hyperplasia of the 
transplanted liver with atrophy of the recipient liver was clearly 
demonstrated by hepatobiliary scanning in our study. In a patient that 
received an auxiliary liver transplant in the presence of end-stage 
cirrhosis hyperplasia of the graft and atrophy of the recipient liver 
could also be demonstrated by this technique27 . There is no doubt that 
isotope scanning is a very valuable method to assess graft function after 
heterotopic liver transplantation. 
7.8 Evaluation of metabolic support 
To evaluate our technique of auxiliary liver transplantation in the 
presence of host liver insufficiency, a suitable animal model of hepatic 
failure was needed. Such a model was developed by temporary inducing 
hepatic ischemia in pigs (Chapter 4). Although technically somewhat 
complicated it proved to fulfil the criteria for a 
model of acute hepatic failure as compiled by 
satisfactory animal 
Terblanche59 . These 
include: (1) potential reversibility; (2) reproducibility; (3) death 
due to hepatic coma after elapse of a time period sufficiently long to 
allow hepatic support procedures to be instituted; (4) the use of a large 
animal; (5) induction of liver necrosis without biohazard. All animals 
subjected to six hour liver ischemia developed severe encephalopathy, a 
rise in plasma ammonia levels, and increased plasma ratio's for tyrosine 
and phenylalanine. Hepatic coma and death was encountered in all these 
animals, and because of the reproducibility of this set of phenomena, it 
seemed appropriate to test auxiliary partial liver transplantation as a 
supportive measure in these pigs. It has been calculated that only 
0.03-3.0% of the clearance capacity for putative toxins of the normal 
liver can be replaced by todays hemoperfusion and hemodialytic 
procedures60 At least 20% of the capacity of the normal liver to remove 
these toxins is estimated to be required for survival 60 To date liver 
transplantation seems to be the only support system available that can 
theoretically take over this detoxification capacity. Auxiliary partial 
liver transplantation sustained life in pigs with acute liver failure in 
the fourth and fifth experiment, whereas animals without a transplant all 
died of hepatic failure. The synthetic function of the failing liver was 
adequately taken over by the graft, as demonstrated by synthesis of 
clotting factors. In the clinical situation it has been shown that the 
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auxiliary liver can provide sufficient metabolic support as two patients 
have survived seven and thirteen years after such a procedure14 •27 After 
extensive liver resections in man, life can be sustained as long as about 
a fifth of the total liver remains functiona1 61 . We therefore assume that 
transplantation of 60% of a donor liver will be sufficient as support 
system in future clinical auxiliary liver transplantation. 
7.9 Clinical prospects for auxiliary partial liver transplantation 
Before proceeding to auxiliary liver transplantation in man one has to 
investigate whether the vascular anastomoses as performed in the 
experimental animal are feasible in man. An anatomical study in human 
cadavers was performed to find out if partial liver grafts could be placed 
in the subhepatic position as we used in our animal studies (unpublished 
observations). Vascular anastomoses could be established in all cases and 
were not more difficult than in the porcine experiments. Reduction of the 
graft by left hemihepatectomy facilitated the placement of the caval 
anastomosis just above or at the level of the renal veins. These 
observations are in accordance with conclusions from other human cadaver 
studies 62 · 63 . 
Candidates for experimental clinical partial liver transplantation are in 
orthotopic 
the case 
liver transplantation is 
in most patients with 
the first place those patients where 
currently not considered. This is 
fulminant hepatic failure 64 . An important aspect of the definition of 
fulminant hepatic failure as stated in Chapter 1.1, is the absence of 
preexisting liver disease which implies that, if the patient survives, 
hepatic structure and function might return. Such patients are in 
desperate need of an adequate hepatic support system. The patients that 
during intensive care treatment fail to respond within a 3-5 days, or 
appear to have a (sub)total liver necrosis confirmed by laparoscopy and 
histopathological studies, should be considered as 
auxiliary partial liver transplantation. The chance 
survival after intensive supportive care in these patients 
candidates for 
of spontaneous 
is minimal 65 . 
Early transferral to the transplantation centre is mandatory so that 
response to conventional therapy can be closely monitored a 
consideration for transplantation can be made without delay. 
Another group of patients that might benefit from auxiliary partial liver 
transplantation are the patients with chronic end-stage liver diseases 
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that are not accepted ~or orthotopic liver transplantation. There are 
important differences in patient selection among the main transplantation 
centers54 . Patients that are currently not accepted in one center may 
have a chance in another. In The Netherlands selection criteria for 
orthotopic liver transplantation are rather stringent. Untill January 
1985, 374 patients were referred as potential candidates for orthotopic 
liver transplantation but only 40 were actually tr~~splanted66 . Fourty 
seven patients with chronic active cirrhosis or primary biliary cirrhosis 
were not accepted because of badly deteriorated liver function and the 
change of a successful liver transplantation was thought to be not likely. 
Since there is no alternative therapy ~or these patients auxiliary partial 
liver transplantation might be justi~ied ~rom an ethical point o~ view in 
these otherwise hopeless situations. The risk o~ a coincidental primary 
hepatic malignancy in the host liver, not detected preoperatively, should 
be considered in these patients. However, that risk is small: only 13 
patients (2.6%) who had liver replacement to treat end-stage liver disease 
were ~ound to have a coincidental liver tumor out o~ 500 patients that 
received an orthotopic liver transplant in that same period11 . 
Children with genetic liver disease are also potential candidates ~or 
auxiliary partial liver transplantation. Metabolic errors that do not 
primarily af~ect the liver such as type I Crigler-Najjar syndrome, 
protoporphyria, and ~amilial hypercholesterolemia might be treated 
theoretically by a small auxiliary liver transplant 67 . On an individual 
and selective basis an auxiliary partial liver transplant could be 
per~ormed in these patients, although problems related to ·~unctional 
competition' have so ~ar not been elucidated su~~iciently experimentally. 
According to the Dutch Central Bureau o~ Statistics the number of patients 
that die each year as a result o~ 'acute non-in~ectious-hepatitis' is 
about 25 patients. In addition 15 patients die yearly o~ 'non-in~ectious 
hepatitis not-speci~ied'. Based on these mortality ~igures the number o~ 
patients that might be expected to require an auxiliary liver transplant 
in this group is estimated to be 40 yearly at the most. The number o~ 
patients expected to be in need o~ an auxiliary liver transplant in the 
group o~ patients with end-stage chronic liver disease is hard to de~ine 
and will depend upon the indications used and the number o~ patients that 
is rejected ~or orthotopic liver transplantation. Because there is a well 
organized organ procurement program in The Netherlands, an adequate number 
o~ donor livers will probably be available to match the need68 , especially 
as the liver, heart, and both kidneys can be procured ~rom a single donor 
without compromising the anatomy and preservation of any o~ the organs69 . 
Auxiliary liver transplantation with partial gra~ts from living related 
donors is theoretically possible. Clinical auxiliary autotransplantation 
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of the left liver lobe has been reported once70 This attempt was not 
successful because the basic requirements for optimal gra£t function, as 
outlined in Gapter 1 .5. were not met. Clinical auxiliary partial liver 
transplantation using living related donors is currently not justified as 
no experimental data on this subject exist. 
7.10 Conclusions 
The objectives of this study as formulated in Chapter 1 .6, have been 
achieved. 
1 . A method of auxiliary partial liver transplantation has been 
developed in the dog. All theoretical requirements for optimal 
graft function as stated in Chapter 1.5 were met. The same 
method could be applied to pigs without essential modifications. 
2. Concerning the effects of tissue typing it is concluded that 
DLA-matching in the dog experiments improved graft survival after 
auxiliary partial liver transplantation. The transplants in 
non-tissue-typed donor recipient canine combinations were subject 
to acute rejection. In the porcine experiments, acute rejection 
of auxiliary partial liver grafts in non-tissue-typed 
combinations did not occur. 
3. A model of transient acute hepatic failure was developed in the 
pig. Liver ischemia for four hours did not result in lethal 
hepatic failure in all cases. Six hours of hepatic ischemia, 
however, resulted in hepatic failure and severe encephalopathy, 
leading to death within three days. This period between hepatic 
failure and death was sufficiently long enough, to assess 
auxiliary transplantation of part of the liver as a support 
system. 
4. It was demonstrated that an auxiliary partial liver transplant 
can provide sufficient metabolic support and can improve survival 
in pigs with acute liver failure, induced before or after the 
transplantation procedure. There was some evidence of hepatic 
regeneration in the auxiliary partial liver grafts. Regeneration 
in the ischemically damaged recipient liver was found twice in 
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pigs where liver failure was induced before the transplantation 
procedure. 
5. Finally, it was feasible to perform auxiliary partial liver 
transplantation in severely ill pigs with acute liver failure, 
although postoperative mortality rate was high. Intensive 
perioperative monitoring was necessary to correct hemodynamic 
disturbances. Reduction of the time interval between induction 
of liver failure and transplantation from 13 to 3 hours improved 
the condition of the animals and may have influenced differences 
in graft survival. Severe coagulation disorders that suggested 
intravascular coagulation, were seen following recirculation of 
the ischemic host liver. 
As a result of these experiments it seems justified to further explore the 
possibilities of auxiliary partial liver transplantation in man. 
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SUMMARY 
In this thesis studies on auxiliary partial liver transplantation in the dog 
and the pig are reported. The motive to perform this study was the fact 
that patients with acute hepatic failure or end-stage chronic liver disease 
are often considered to form too great a risk for successful orthotopic 
liver transplantation. Auxiliary partial liver transplantation may offer a 
solution for those patients. 
In the introduction to this thesis in Chapter 1 the indication for liver 
transplantation is discussed. Potential advantages of auxiliary liver 
transplantation compared with the orthotopic technique are lined out. The 
results in the limited number of patients so far treated by auxiliary liver 
transpl~~tation are reported. A review is given of the literature on 
experiments in laboratory animals in which the technique of auxiliary liver 
transplantation was tested. Attention is focussed on problems of space, 
position and blood supply to the graft. It appeared that optimal conditions 
in auxiliary liver transplantation demands small or partial donor livers and 
that the transplant should have a low outflow pressure, adequate hepatic 
arterial inflow as well as adequate inflow of portal venous blood. Problems 
related to biliary drainage and rejection are discussed. 
The essential part of this thesis is our own experimental work, reported in 
the Chapters 2, 3, 4, 5, and 6. A surgical technique of auxiliary partial 
liver transplantation was developed and studied in the dog and the pig. In 
porcine experiments metabolic support of auxiliary partial liver transplants 
in the presence of acute host liver failure was investigated. All 
experiments were performed in the Laboratory for Experimental Surgery of the 
Erasmus University, Rotterdam. The five chapters are written in the form of 
scientific papers. Chapter 2, 3. 4 and 5 have been published (2, 5) or have 
been accepted (3, 4) for publication. Chapter 6 has been submitted for 
publication. 
In Chapter 2 (first 
transplantation of 60~ 
experiment) a technique for auxiliary liver 
of a donor liver is described in the dog in which all 
criteria for optimal graft function are met. The effect of matching for the 
major histocompatibility complex on liver allograft survival is reported. 
Long-term transplant survival was found in DLA-identical littermate beagles. 
In non-tissue-typed donor-recipient combinations most transplants were 
subject to acute rejection. 
In Chapter 3 (second experiment) the feasibility of our technique of 
auxiliary partial liver transplantation and rejection phenomena were studied 
in pigs. Advantages of the use of the pig in liver transplantation 
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experiments include similarity of the pig liver to the human liver with 
regard to the macroscopic and microscopic structure. Transplantations were 
first performed in non-tissue-typed donor-recipient combinations without 
immunosuppressive medication. No problems were encountered from changing 
our laboratory animal and no essential technical modifications had to be 
made. In contrast to findings by others in orthotopic liver 
transplantation, the porcine graft was subject to immune attack albeit 
milder than encountered in the canine experiments. 
In the experiments described in Chapter 4 (third experiment) a model of 
acute hepatic failure was developed in the pig. Six hours total liver 
ischemia resulted in grade 4 encephalopathy and death of subtotal liver 
necrosis within 50 hours. Encephalopathy, rise in ammonia levels and plasma 
ratios for putative toxins were comparable to the human condition of acute 
hepatic failure. And as such our large animal model fulfilled the accepted 
criteria of a satisfactory animal model of acute hepatic failure. 
In Chapter 5 (fourth experiment) ischemic liver cell necrosis was induced 
four days after auxiliary partial liver transplantation. Excellent graft 
function and metabolic support was demonstrated by, ammonia detoxification. 
synthesis of clotting factors, and glucohomeostasis. Seven out of thirteen 
animals survived in excellent condition untill sacrifice at 26 days after 
induction of acute liver failure. Evidence of hepatic regeneration was 
found in the transplants but not in the damaged host liver. 
The experiment described in Chapter 6 (fifth experiment) deals with 
hemodynamics and coagulation disorders in pigs where ischemic liver cell 
necrosis was induced before auxiliary partial liver transplantation. 
Hypotension and poor animal condition resulted in early death in 9 out of 11 
pigs that received an auxiliary partial liver transplant thirteen hours 
after induction of liver failure. Reduction of the time interval between 
induction of liver failure and transplantation to three hours. improved the 
animal condition at the beginning and during the auxiliary partial liver 
transplantation, as evidenced by the higher blood pressure compared to the 
first group. Reduction of the time interval, however, did not improve the 
animal survival, as only two pigs out of ten survived more than two weeks 
after auxiliary partial liver transplantation. Decrease in cardiac output 
and increase of pulmonary and systemic vascular resistance was observed 
during auxiliary liver transplantation. Deficiencies in hemostasis 
explained by consumptive coagulopathy rather than fibrinolysis were noted 
that correlated with poor animal prognosis. In the four longer surviving 
pigs of both groups either the graft or the host liver recovered. 
In Chapter 7 the foregoing experiments and clinical prospects for auxiliary 
partial liver transplantation are discussed. 
partial liver transplantation is technically 
It is concluded that auxiliary 
feasible in dogs and pigs. 
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Suf~icient metabolic support was demonstrated in the presence of acute host 
liver failure. Efforts should be made to further evaluate the possibilities 
of auxiliary partial liver transplantations in man. 
139 
S~~ATTING 
In dit proe£schrift worden experimenten beschreven, die betrekking hebben op 
auxiliaire parti§le levertransplantatie bij de hand en het varken. Dit 
onderzoek werd verricht omdat het risico een orthotope 
levertransplantatie bij patienten met een acute leverinsufficientie of 
terminale chronische leverinsufficientie vaak te groat wordt geacht. Voor 
deze patientengroep zou auxiliaire partiele levertransplantatie een 
oplossing kunnen bieden. 
De indicatie voor levertransplantatie wordt besproken in de inleiding tot 
dit proefschrift in hoofdstuk 1. De potentiele voordelen van de auxiliaire 
levertransplantatie in vergelijking met de orthotope techniek worden 
vermeld. Van de 
werd behandeld met 
Rierna volgt een 
resultaten in de kleine patientengroep die tot dusverre 
auxiliaire levertransplantatie vordt verslag gedaan. 
overzicht van de literatuur betre££ende experimenten in 
proe£dieren. waarbij de techniek van auxiliaire levertransplantatie werd 
onderzocht. In het bijzonder wordt de aandacht gevestigd op het probleem 
van ruimtegebrek bij de ontvanger. en op de positie en de bloedvoorziening 
van het transplantaat. Het bleek dat auxiliaire levertransplantatie het 
beste kan worden verricht met kleine donorlevers o£ een deel van een 
donorlever. De druk in de afvoerende venen van het transplantaat meet laag 
zijn en het transplantaat meet verden voorzien van voldoende arterieel en 
portaal bleed. Problemen met betrekking tot de gala£vloed en de afstoting 
worden besproken. 
Het belangrijkste gedeelte van dit proefschrift vordt gevormd door ens eigen 
experimentele werk, dat wordt beschreven in de hoofdstukken 2, 3, 4. 5 en 6. 
Een methode van auxiliaire partiele levertransplantatie werd ontwikkeld en 
bestudeerd bij de hand en het varken. Bij varkens met acute 
leverinsuffici~ntie werd onderzocht of het auxiliaire partiele 
levertransplantaat de metabole functies van de zieke lever kon ondersteunen. 
De experimenten werden alle verricht in het Laboratorium voor Experimentele 
Chirurgie van de Erasmus Universiteit te Rotterdam. De vijf hoofdstukken 
zijn geschreven als wetenschappelijke publicaties. Hoofdstuk 2, 3, 4 en 5 
werden gepubliceerd (2, 5) of geaccepteerd voor publicatie (3, 4). 
Hoofdstuk 6 werd ter publicatie aangeboden. 
In hoofdstuk 2 (eerste experiment) wordt een model van auxiliaire 
levertransplantatie bij de hand beschreven, waarbij 60% van een donorlever 
wordt gebruikt en waarbij aan alle voorwaarden wordt voldaan die 
noodzakelijk zijn om het transplantaat optimaal te kunnen laten 
functioneren. Het effect van de mate van overeenkomst van de belangrijkste 
histocompatibiliteits antigenen van donor en ontvanger op de overleving van 
het levertransplantaat wordt beschreven. Langdurige transplantaat 
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overleving werd gezien bij transplantaties tussen DLA identieke beagle 
-littermates-. Transplantaties tussen donor en ontvanger waarbij geen 
wee£seltypering was verricht resulteerden meestal in acute transplantaat 
afstoting. 
In hoofdstuk 3 (tweede experiment) wordt verslag gedaan van een experiment 
bij varkens. waarbij de uitvoerbaarheid van onze methode van auxiliaire 
partiele levertransplantatie en de transplantaat afstoting bij dit 
proefdier werden bestudeerd. Een van de voordelen van het gebruik van 
varkens bij levertransplantatie experimenten is de overeenkomst in 
macroscopische en microscopische structuur tussen de varkenslever en de 
menselijke lever. Er werden transplantaties verricht tussen donor en 
ontvanger combinaties waarbij geen weefseltypering had plaatsgevonden en 
waarbij geen immunosuppressieve medicatie werd gegeven. Het veranderen van 
proefdier leverde geen problemen op en er waren geen essentiele wijzigingen 
in techniek noodzakelijk. Het transplantaat wekte bij het varken een 
afstotingsreactie op. die welliswaar minder heftig verliep dan wij bij de 
experimenten in de bond hadden gezien. doch die door andere onderzoekers bij 
orthotope levertransplantatie in het varken niet werd waargenomen. 
In hoofdstuk 4 (derde experiment) worden experimenten beschreven waarbij een 
model van acute leverinsufficientie bij het varken werd ontwikkeld. 
Ischaemie van de lever gedurende 6 uur leidde tot ernstige 
de dood binnen 50 uur tengevolge (graad 4) 
levernecrose. 
stijging van 
en tot 
De encephalopathie, 
de plasmaratio's 
de toename van het 
van de verschillende 
encephalopathie 
van subtotale 
ammoniak en de 
toxinen waren 
vergelijkbaar met hetgeen, in geval van acute leverinsufficientie bij de 
mens wordt gezien. Dit model van acute leverinsufficientie bij een greet 
proefdier voldeed als zodanig aan de daarvoor geaccepteerde criteria. 
In hoofdstuk 5 (vierde experiment) werd vier dagen na auxiliaire parti8le 
levertransplantatie ischaemische levercelnecrose veroorzaakt bij varkens. 
Het transplantaat functioneerde voortreffelijk zeals bleek uit de daling van 
de plasma concentratie van ammoniak. de synthese van stollingsfactoren en 
een normale bloedsuiker spiegel. Zeven van de dertien proefdieren 
overleefden in goede conditie, totdat ze werden opgeofferd 26 dagen na de 
inductie van acute leverinsuffici8ntie. In de transplantaten ken 
leverregeneratie worden aangetoond doch dit werd niet gezien in de 
beschadigde levers van de ontvangers. 
In hoofdstuk 6 (vijfde experiment) wordt een experiment beschreven waarbij 
hemodynamische veranderingen en stollingsstoornissen worden onderzocht bij 
varkens, waarbij ischaemische levercelnecrose was geinduceerd v66rdat 
auxiliaire parti8le levertransplantatie had plaatsgevonden. De proefdieren 
die een auxiliair partieel levertransplantaat kregen 13 uur na de inductie 
van leverinsuffici8ntie hadden een lage bloeddruk en verkeerden in slechte 
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algemene conditie. Negen van de 11 proefdieren stierven spoedig na de 
transplantatie. Bij een t~eede groep proefdieren werd de periode tussen de 
inductie van leverinsufficientie en transplantatie teruggebracht tot 3 uur. 
Dit had tot gevolg dat de conditie en de bloeddruk van de proefdieren 
verbeterde in vergelijking tot de eerste groep, zowel aan het begin als 
tijdens de auxiliaire partieele levertransplantatie. De overleving van de 
proefdieren verbeterde echter niet nadat de periode tussen de inductie van 
leverinsufficientie en de transplantatie was teruggebracht. Van de tweede 
groep overleefden slechts 2 van de 10 proefdieren meer dan twee weken na de 
auxiliaire partiele levertransplantatie. Tijdens de auxiliaire 
levertransplantatie werd een vermindering gezien van de 'cardiac output' en 
een toename van de vaatweerstand in de longen en in de periferie. 
Stollingsstoornissen bleken eerder te worden veroorzaakt door verbruiks 
coagulopathie dan door fibrinolyse en correleerden met een geringe 
overleving van het proefdier. Er trad herstel op hetzij van de eigen lever 
hetzij van het transplantaat in de vier varkens van beide groepen die 
gedurende lange tijd overleefden. 
In hoofdstuk 7 worden de voorafgaande experimenten en de mogelijkheden voor 
klinische toepasbaarheid van auxiliaire partiele levertransplantatie 
besproken. Er wordt 
levertransplantatie technisch 
transplantaat blijkt in 
geconcludeerd 
mogelijk 
staat bij 
is 
dat auxiliaire partiele 
in honden en varkens. Ret 
een proefdier met acute 
leverinsuffici§ntie de metabole functies van de zieke lever voldoende te 
kunnen ondersteunen. De mogelijkheid auxiliaire parti§le 
levertransplantatie bij de mens zou nader onderzocht moeten worden. 
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